	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S17-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S17-BMJ_2010_Apr_29_340_c1640	['this latitudinal gradient SEEMS environmentally RELATED BECAUSE the risk ASSOCIATED with latitude alters if People move after Birth.45a strong environmental CANDIDATE is the level of ambient regional ultraviolet radiation, acting EITHER directly OR through the generation of Vitamin D.6higher exposure to ultraviolet radiation,7higher Vitamin D intake,8and also higher Serum Vitamin D concentrations9seem to be ASSOCIATED with a reduced risk of onset of multiple sclerosis.']	[('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 73), ('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230), ('SUPERFICIAL_RELATIONSHIP', 411)]	7	[('NCBITaxon_10088', 'Mus <genus>', 108, 'people'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('UBERON_0001977', 'blood serum', 369, 'serum'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D')]
S18-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
S103-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
S104-PMC2290997	PMC2290997	4/2008	S104-PMC2290997	['EVEN in the sun-rich environment of the middle east, insufficient Vitamin D is a SEVERE PROBLEM among Breast-Fed infants of women who wear a burqa (a traditional garment that covers the body from Head to Foot), as reported in the february 2003 journal of pediatrics .']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 81), ('IMPORTANT_CONSIDERATION', 88), ('PROBLEM_COMPLICATION', 88)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'breast'), ('GO_0007631', 'feeding behavior', 109, 'fed'), ('UBERON_0000033', 'head', 196, 'head'), ('UBERON_0002387', 'pes', 204, 'foot')]
S13-PMC2396486	PMC2396486	6/2008	S13-PMC2396486	['given that Vitamin D levels in the population fluctuate across the seasons and decrease across higher latitude[4], low Prenatal Vitamin D ‘FITS’ these key environmental features and is THEREFORE a PLAUSIBLE CANDIDATE risk factor for this disease.']	[('SUPERFICIAL_RELATIONSHIP', 139), ('PROBABLE_UNDERSTANDING', 185), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 207)]	4	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'prenatal'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
S90-PMC2798111	PMC2798111	12/2010	S90-PMC2798111	['discussion\nbecause the PRELIMINARY results of this arm of the trial are IMPORTANT for decision-making in the current clinical environment, we report HERE the interim results of an ONGOING Vitamin D supplementation TRIAL of Lactating women and their infants.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 72), ('QUESTION_ANSWERED_BY_THIS_WORK', 149), ('IMPORTANT_CONSIDERATION', 180), ('INCOMPLETE_EVIDENCE', 214)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 223, 'lactating')]
S34-PMC2872349	PMC2872349	4/2010	S34-PMC2872349	['rickets has served as a longstanding example of an adverse Early Life environment, in the form of Vitamin D deficiency, disrupting the process of Bone Development and untreated CAN LEAD TO persistent changes in the child’s bone structure.']	[('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 181)]	2	[('UBERON_0001847', 'lobule of pinna', 59, 'early life'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0048539', 'bone marrow development', 146, 'bone development')]
S118-PMC2872349	PMC2872349	4/2010	S118-PMC2872349	['a further example of a dynamic INTERACTION between Genetic and environmental INFLUENCES of bone mass was shown in the analysis of the Vitamin D Receptor (vdr) genotype and Adult bmd in participants of the hertfordshire cohort study.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('SO_0000704', 'gene', 51, 'genetic'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 134, 'vitamin D receptor'), ('UBERON_0007023', 'adult organism', 172, 'adult')]
S112-PMC2898025	PMC2898025	5/2010	S112-PMC2898025	['children who live in polluted, inner city environments and who are deprived of regular sunlight exposure HAVE BEEN SHOWN to suffer a higher prevalence of rickets (due to Vitamin D deficiency) than children in rural areas [148].']	[('INCOMPLETE_EVIDENCE', 105)]	1	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
S0-PMC2913107	PMC2913107	8/2010	S0-PMC2913107	['on the aetiology of autism\ni have SUGGESTED that the primary environmental TRIGGER for autism is not vaccinations, Toxins or infections, BUT Gestational and early childhood Vitamin D deficiency (1,2).']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	3	[('CHEBI_27026', 'toxin', 115, 'toxins'), ('GO_0007565', 'female pregnancy', 141, 'gestational'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
S1-PMC2913107	PMC2913107	8/2010	S1-PMC2913107	['subsequently, the title of an article in scientific american RECENTLY ASKED, ‘WHAT IF Vitamin D deficiency is a cause of autism?’ (3) since then, an ARTICLE on Vitamin D and autism in acta paediatrica (4) and the accompanying COMMENTARY (5) have added to the ACCELERATING SUSPICION that Vitamin D deficiency – EITHER during Pregnancy OR early childhood – MAY BE an environmental TRIGGER for the Genetic disease of autism.']	[('INCOMPLETE_EVIDENCE', 61), ('EXPLICIT_QUESTION', 70), ('EXPLICIT_QUESTION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('EXPLICIT_QUESTION', 127), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 226), ('IMPORTANT_CONSIDERATION', 259), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 272), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 310), ('INCOMPLETE_EVIDENCE', 355), ('SUPERFICIAL_RELATIONSHIP', 379)]	12	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('SO_0000704', 'gene', 395, 'genetic')]
S137-PMC2963768	PMC2963768	10/2010	S137-PMC2963768	"[""a PLAUSIBLE HYPOTHESIS is that Vitamin D deficiency ACTS SYNERGISTICALLY with OTHER causes of INADEQUATE bone mineralization and that an Individual's 25(Oh)D concentration below which clinical signs emerge DEPENDS ON the severity and multiplicity of OTHER Genetic and environmental FACTORS.""]"	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 250), ('SUPERFICIAL_RELATIONSHIP', 282)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_1', 'root', 137, 'individual'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 150, '25 ... OH ... D'), ('SO_0000704', 'gene', 256, 'genetic')]
S204-PMC2996405	PMC2996405	11/2010	S204-PMC2996405	['IT IS POSSIBLE to SPECULATE that a selective pressure COULD have favoured a Haplotype containing the t Allele in an environment with low Vitamin D availability, for its positive EFFECT on the bone phenotype.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('SO_0001024', 'haplotype', 76, 'haplotype'), ('SO_0001023', 'allele', 103, 'allele'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
S20-PMC3004407	PMC3004407	12/2010	S20-PMC3004407	['EARLIER REPORTS of Vitamin D deficiency during Pregnancy have focused on women living in northern europe (latitude 50–55°n), which DID NOT include women of diverse racial/ethnic backgrounds living in a sun-rich environment [5,31,32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 131)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy')]
S23-PMC3004407	PMC3004407	12/2010	S23-PMC3004407	['the AIM of THIS STUDY was to define the prevalence of Vitamin D deficiency in a large and ethnically diverse cross-sectional sample of Pregnant women living in a sun-rich environment with ample access to sunlight during most of the year.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 135, 'pregnant')]
S152-PMC3004407	PMC3004407	12/2010	S152-PMC3004407	['the STRENGTHS of the study are that a large and diverse group of women at various stages of Pregnancy were studied to: (1) ascertain their Vitamin D status at the time of presentation to a community health center and (2) find WHAT FACTORS were most PREDICTIVE of that status in a sun-rich environment where THEORETICALLY there are no LIMITATIONS to achieving an adequate Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 4), ('EXPLICIT_QUESTION', 226), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 249), ('INCOMPLETE_EVIDENCE', 307), ('INCOMPLETE_EVIDENCE', 334)]	6	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin D')]
S10-PMC3075531	PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]
S12-PMC3075531	PMC3075531	7/2010	S12-PMC3075531	['there are DIFFERENCES in OPTIMAL level of 25-Hydroxy Vitamin D BUT nowadays internationally ACCEPTED normal range is between 75 nmol/l and 200 nmol/l, and we CONSIDER Serum level below 75 nmol/l and below 2 nmol/l as insufficiency and deficiency, respectively.42325even it SEEMS to achieve the prevention of Autoimmune diseases, the Serum level of Vitamin D MUST BE higher than the level required to reduce osteoporosis (higher than 75 nmol/l).4in attention to high prevalence of ms in iran and especially in isfahan which is ABOUT 43.5/100,0002627and GIVEN that iran is located in an latitude of 32° 50’ and longitude of 51° 43’ with enough sun exposure and BECAUSE nobody INVESTIGATED the RELATIONSHIP between Vitamin D, AS an environmental agent, and ms disease in iran before, we DECIDED to compare the Serum level of 25-Hydroxy Vitamin D in ms patients and healthy control group in isfahan region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 158), ('ANOMALY_CURIOUS_FINDING', 273), ('IMPORTANT_CONSIDERATION', 358), ('INCOMPLETE_EVIDENCE', 526), ('PROBABLE_UNDERSTANDING', 552), ('PROBABLE_UNDERSTANDING', 659), ('QUESTION_ANSWERED_BY_THIS_WORK', 674), ('SUPERFICIAL_RELATIONSHIP', 691), ('PROBABLE_UNDERSTANDING', 723), ('QUESTION_ANSWERED_BY_THIS_WORK', 784)]	14	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 42, '25-hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum'), ('UBERON_0001442', 'skeleton of manus', 308, 'autoimmune'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 712, 'vitamin D'), ('UBERON_0001977', 'blood serum', 807, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 822, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 841, 'D')]
S43-PMC3075531	PMC3075531	7/2010	S43-PMC3075531	['relative to sun exposure, diet is a POOR source of Colecalciferol, providing ONLY 40-400 iu per Food serving,12WHEREAS whole-body uvb exposure for 20 min for a light-skinned Person during the summer months will produce AT LEAST 10,000 iu.713HOWEVER, increased skin pigmentation, age, use of sunscreen, built environment, and environmental FACTORS that reduce the strength of uvb reaching the earth’s surface (e.g., winter season, high latitude, pollution, cloud cover, and Ozone levels) all CONTRIBUTE to reduce skin Colecalciferol production to the point at which diet MIGHT become the primary source.7–14BECAUSE Melanin Pigment in Human skin absorbs uvb,28black People have lower 25 Hydroxyvitamin D concentrations than white People, and are OFTEN Vitamin D deficient.21HOWEVER, the risk of ms in black People is lower than in white People (BECAUSE of Genetic differences).28analyses of the RELATION between Vitamin D status and ms risk are THEREFORE BETTER done separately within each race/ethnic group.']	[('IMPORTANT_CONSIDERATION', 36), ('ANOMALY_CURIOUS_FINDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('PROBABLE_UNDERSTANDING', 219), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241), ('SUPERFICIAL_RELATIONSHIP', 339), ('SUPERFICIAL_RELATIONSHIP', 491), ('INCOMPLETE_EVIDENCE', 570), ('PROBABLE_UNDERSTANDING', 606), ('PROBABLE_UNDERSTANDING', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 772), ('PROBABLE_UNDERSTANDING', 843), ('SUPERFICIAL_RELATIONSHIP', 893), ('PROBABLE_UNDERSTANDING', 943), ('IMPORTANT_CONSIDERATION', 953)]	15	[('CHEBI_50553', 'mancude carbobicyclic parent', 51, 'colecalciferol'), ('CHEBI_33290', 'food', 96, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 174, 'person'), ('CHEBI_25812', 'ozone', 473, 'ozone'), ('CHEBI_50553', 'mancude carbobicyclic parent', 517, 'colecalciferol'), ('CHEBI_25179', 'melanins', 614, 'melanin'), ('CHEBI_26130', 'biological pigment', 622, 'pigment'), ('NCBITaxon_9606', 'Homo sapiens', 633, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 664, 'people'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 682, '25 hydroxyvitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 728, 'people'), ('CHEBI_27300', 'vitamin D', 750, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 805, 'people'), ('NCBITaxon_10088', 'Mus <genus>', 835, 'people'), ('SO_0000704', 'gene', 854, 'genetic'), ('CHEBI_27300', 'vitamin D', 910, 'vitamin D')]
S61-PMC3075531	PMC3075531	7/2010	S61-PMC3075531	['conclusions\nin conclusion, THIS STUDY SHOWED that Serum Vitamin D deficiency MIGHT be a POTENTIAL environmental predisposing FACTOR for developing multiple sclerosis in our region, and NEED to follow FACTORS that cause THIS PROBLEM including dietary, Genetic, and other ones.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 185), ('SUPERFICIAL_RELATIONSHIP', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 219), ('IMPORTANT_CONSIDERATION', 224)]	9	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('SO_0000704', 'gene', 251, 'genetic')]
S5-PMC3257641	PMC3257641	3/2010	S5-PMC3257641	['1. review\nthe high PREVALENCE of Vitamin D insufficiency during Pregnancy is increasingly RECOGNIZED, amid GROWING EVIDENCE that the Intrauterine environment CAN have both immediate and long-lasting EFFECTS on health of the offspring.']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 90), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 199)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('UBERON_0022293', 'reproductive gland secretion', 133, 'intrauterine')]
S43-PMC3257641	PMC3257641	3/2010	S43-PMC3257641	['furthermore, SINCE 25(Oh)D is stored in Adipose Tissue, there is SOME EVIDENCE that obesity is a FURTHER RISK FACTOR for Vitamin D insufficiency.nutrients-02-00389-t001_table 1\n\ncaption (table-wrap): table 1\n\nrisk factors for Vitamin D deficiency.low ambient uvr level high latitude locationwinter season inadequate sun exposure built or indoor environmentextensive clothing cover (e.g., veiled)excess sun avoidance – (shade, sunscreen) host factors dark skin pigmentationold ageobesitymalabsorptive syndromes (e.g., inflammatory Bowel disease)\nMANY STUDIES HAVE REPORTED on the Vitamin D status of Pregnant women, in a range of environments (summarized intable 2, including studies from 1997–2006).']	[('PROBLEM_COMPLICATION', 13), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 558)]	6	[('CHEBI_71657', 'versiconol acetate', 19, '25(OH)D'), ('UBERON_0001013', 'adipose tissue', 40, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000160', 'intestine', 530, 'bowel'), ('CHEBI_27300', 'vitamin D', 579, 'vitamin D'), ('GO_0007565', 'female pregnancy', 599, 'pregnant')]
S28-PMC3277098	PMC3277098	12/2011	S28-PMC3277098	['lifestyle patterns and environments that do not facilitate adequate sun exposure (indoor occupation, “screen time” and active sun avoidance) PREDISPOSE to inadequate Vitamin D synthesis and status.']	[('SUPERFICIAL_RELATIONSHIP', 141)]	1	[('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
S56-PMC3277098	PMC3277098	12/2011	S56-PMC3277098	['given that B and T Cells are INFLUENCED by Vitamin D (section 4.1), there is SPECULATION that Orally Ingested Vitamin D COULD have the POTENTIAL to directly Modulate the function of Lymphocytes in the local Gut micro-environment.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 135)]	4	[('CL_0000969', 'regulatory B cell', 11, 'B ...'), ('CL_0000084', 'T cell', 17, 'T cells'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 94, 'orally'), ('GO_0007631', 'feeding behavior', 101, 'ingested'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0065007', 'biological regulation', 157, 'modulate'), ('CL_0000542', 'lymphocyte', 182, 'lymphocytes'), ('UBERON_0001555', 'digestive tract', 207, 'gut')]
S101-PMC3277098	PMC3277098	12/2011	S101-PMC3277098	['functional consequences of vdr polymorphisms MAY, THEREFORE, vary with the availability of Vitamin D to Tissues and become apparent, OR exaggerated, in an environment of Vitamin d deficiency, such as observed in the case of several infectious diseases [45,46].']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('UBERON_0000479', 'tissue', 104, 'tissues'), ('CHEBI_33229', 'vitamin (role)', 170, 'vitamin')]
S43-PMC3309463	PMC3309463	6/2011	S43-PMC3309463	['it HAS BEEN PROPOSED that developmental Vitamin D deficiency MAY CONTRIBUTE to the increased risk of schizophrenia in dark-skinned migrants and those living in crowded urban settings.28both dark skin and urban residence are ASSOCIATED with an INCREASED risk of hypovitaminosis D.29developmental Vitamin D deficiency MAY also UNDERLIE the well-replicated season of birth EFFECT FOUND in schizophrenia (those Born in winter and spring have a small but significant increased risk of schizophrenia).30vitamin D is a potent pro-differentiation agent and CAN INFLUENCE Brain functioning via many DIFFERENT pathways.31the Vitamin D receptor and the enzyme required for the manufacture of the hormonally active form of Vitamin D have BEEN IDENTIFIED in the Human Brain,32AND THERE IS EVIDENCE from Rodent MODELS DEMONSTRATING that transient Prenatal Vitamin D deficiency results in persistent changes in Adult Brain structure, neurochemistry and behavior.33our species has evolved in settings where Vitamin D is abundant, and migration to colder climates and urban-related lifestyle factors have left modern Humans at increased risk of hypovitaminosis D.\ninspired by the conceptual framework described above, we PROPOSE that the absence of adequate Vitamin D levels during development deprives the Organism of expected instructions from the environment.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 224), ('IMPORTANT_CONSIDERATION', 243), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 325), ('SUPERFICIAL_RELATIONSHIP', 370), ('INCOMPLETE_EVIDENCE', 377), ('INCOMPLETE_EVIDENCE', 549), ('SUPERFICIAL_RELATIONSHIP', 553), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 590), ('ANOMALY_CURIOUS_FINDING', 726), ('INCOMPLETE_EVIDENCE', 731), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 761), ('INCOMPLETE_EVIDENCE', 767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 797), ('INCOMPLETE_EVIDENCE', 797), ('INCOMPLETE_EVIDENCE', 804), ('INCOMPLETE_EVIDENCE', 1204)]	21	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007567', 'parturition', 407, 'born'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 505, 'D'), ('UBERON_0000955', 'brain', 563, 'brain'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 711, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'human'), ('UBERON_0000955', 'brain', 755, 'brain'), ('NCBITaxon_33208', 'Metazoa', 790, 'rodent'), ('GO_0007565', 'female pregnancy', 833, 'prenatal'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin D'), ('UBERON_0007023', 'adult organism', 896, 'adult'), ('UBERON_0000955', 'brain', 902, 'brain'), ('CHEBI_27300', 'vitamin D', 991, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1100, 'humans'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1144, 'D'), ('CHEBI_27300', 'vitamin D', 1241, 'vitamin D'), ('NCBITaxon_1', 'root', 1290, 'organism')]
S51-PMC3309463	PMC3309463	6/2011	S51-PMC3309463	['IF cryptic variation is exposed by environmental exposures, such as Vitamin D deficiency, stress or cannabis use, then Allelic EFFECTS should BE larger in populations where these exposures are prevalent.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 127), ('ANOMALY_CURIOUS_FINDING', 142)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('SO_0001023', 'allele', 119, 'allelic')]
S89-PMC3309463	PMC3309463	6/2011	S89-PMC3309463	['with respect to the epidemiology of schizophrenia, we OUTLINE HOW one CANDIDATE environmental RISK FACTOR, low Prenatal Vitamin D, CAN result in environmental editing of Brain Development.']	[('INCOMPLETE_EVIDENCE', 54), ('EXPLICIT_QUESTION', 62), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 131)]	5	[('GO_0007565', 'female pregnancy', 111, 'prenatal'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D'), ('GO_0007420', 'brain development', 170, 'brain development'), ('UBERON_0000955', 'brain', 170, 'brain')]
S166-PMC3347028	PMC3347028	3/2012	S166-PMC3347028	['GIVES INVALUABLE INSIGHT into Vitamin D status of darker Pigmented Individuals living in a sun-rich environment in eastern africa [141].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 17)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 57, 'pigmented'), ('NCBITaxon_1', 'root', 67, 'individuals')]
S47-PMC3348565	PMC3348565	4/2012	S47-PMC3348565	['procedures\nwe chose a quarterly supplementation regimen because in routine programme conditions a quarterly regimen is LIKELY to have better adherence than a daily regimen,13,14and HAS BEEN shown to be effective at maintaining the Serum Vitamin D concentration within normal ranges for 2–3 months in a french high-risk infant population.16the syringes containing Vitamin D or placebo were stored in conditions recommended by the manufacturer—a dry cool environment—between 2 and 24 weeks before administration.']	[('PROBABLE_UNDERSTANDING', 119), ('INCOMPLETE_EVIDENCE', 181)]	2	[('UBERON_0001977', 'blood serum', 231, 'serum'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D')]
S2-PMC3356951	PMC3356951	4/2012	S2-PMC3356951	['this PANDEMIC of hypovitaminosis d can MAINLY be ATTRIBUTED to lifestyle (for example, reduced outdoor activities) and environmental (for example, air pollution) FACTORS that reduce exposure to sunlight, which is REQUIRED for ultraviolet-b (uvb)-induced Vitamin D Production in the skin.']	[('IMPORTANT_CONSIDERATION', 5), ('PROBABLE_UNDERSTANDING', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 213)]	5	[('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 254, 'vitamin D production')]
S14-PMC3356951	PMC3356951	4/2012	S14-PMC3356951	['[1–3] this PANDEMIC of hypovitaminosis d CAN MAINLY be ATTRIBUTED to lifestyle and environmental FACTORS that reduce exposure to sunlight, which is REQUIRED for ultraviolet-b (uvb)-induced Vitamin D Production in the skin.']	[('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 97), ('IMPORTANT_CONSIDERATION', 148)]	6	[('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0006272', 'leading strand elongation', 197, 'D production')]
S269-PMC3385441	PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
S21-PMC3395583	PMC3395583	7/2012	S21-PMC3395583	['DESPITE these DIFFERENCES, an abnormal Activation Of the Immune System is a common thread LINKING these conditions and several OBSERVATIONS INDICATE that similar Genetic pathways and environmental agents, such as Vitamin D deficiency, smoking behaviour and various infections, are INVOLVED in the pathogenesis of these disorders [18-20,22-25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 281)]	7	[('GO_0000103', 'sulfate assimilation', 39, 'activation of ... immune system'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('SO_0000704', 'gene', 162, 'genetic'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
S91-PMC3395583	PMC3395583	7/2012	S91-PMC3395583	['it MAY BE that in utero Vitamin D deficiency, in conjunction with individual Genetic variation and subsequent exposure to other environmental agents, MAY then LEAD TO disease specificity.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('SO_0000704', 'gene', 77, 'genetic')]
S101-PMC3395583	PMC3395583	7/2012	S101-PMC3395583	['it is IMPORTANT TO NOTE that our uvb and Vitamin D CORRELATION analysis DOES NOT prove causation and that, ALTHOUGH the Vitamin D HYPOTHESIS is SUPPORTED by both epidemiological and functional OBSERVATIONS, seasonality dominates many features of the global environment and OTHER seasonal factors MAY play a ROLE in determining the risk of id.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 51), ('ANOMALY_CURIOUS_FINDING', 72), ('ANOMALY_CURIOUS_FINDING', 107), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 296), ('SUPERFICIAL_RELATIONSHIP', 307)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
S66-PMC3417531	PMC3417531	7/2012	S66-PMC3417531	"[""(91)childreninfectious diseasehigh rate of simkania negevensis among canadian inuit infants hospitalized with Lower Respiratory Tract infections (92)childrennutritioniron deficiency and anaemia prevalence and ASSOCIATED etiologic RISK FACTORS in first nations and inuit communities in northern ontario and nunavut (93)childrennutritionfood insecurity among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (59)childrennutritionvitamin D status of inuit preschoolers reflects season and Vitamin D intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect of Prenatal exposure to Polychlorinated Biphenyls on incidence of acute Respiratory infections in preschool inuit children (25)childrenchronic disease; interventions/programmingthe benefits of sound field amplification in classrooms of inuit students of nunavik: a pilot project (73)childrensocial DETERMINANTS of health; tobaccocultural, socioeconomic, and health indicators among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air quality and the risk of Lower Respiratory Tract infections in young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators prevent Respiratory disorders in inuit children (40)childrengenetics; nutritionadaptation of inuit children to a low-calcium diet (83)childreninfectious disease; health care, policy, Human resourcesbronchiolitis in inuit children from a canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses and CONTRIBUTIONS to differences in Life expectancy for inuit nunangat and canada, 1994–2003 (82)youthinfectious diseaseotitis media and Hearing loss among 12–16 year-old inuit of inukjuak, quebec, canada (35)youthinjuryinjury mortality risk assessment and targeting the subpopulations for prevention in the northwest territories, canada (86)youthnutritionage differences in Vitamin A intake among canadian inuit (55)youthmental health and wellbeingcompleted suicides among the inuit of northern quebec, 1982–1996: a case-control study (77)youthmental health and wellbeing; social determinants of healthsuicidality in a sample of arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences of aboriginal youth in canada: service IMPLICATIONS (74)youthinfections disease; social determinants of healthdeterminants of Sexually Transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental health and wellbeingyouth sexual health in nunavut: a needs-based survey of knowledge, attitudes and behaviour (31)maternalbirth outcomesreclaiming Birth, health, and community: midwifery in the inuit villages of nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels in maternal and Umbilical Cord Blood Plasma in arctic canada (49)maternalenvironment/environmental exposuresexposure of the inuit population of nunavik (arctic quebec) to lead and mercury (48)maternalnutritiondietary assessment of indigenous canadian arctic women with a focus on Pregnancy and Lactation (54)maternalnutritioncontribution of selected traditional and market Foods to the diet of nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking at first Prenatal visit as a MARKER of risk for adverse Pregnancy outcomes in the qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish Consumption and Blood Lipids in 3 ethnic groups of quebec (canada) (51)maternalhealth care, policy, Human resources; Birth outcomesconverging epistemologies: CRITICAL ISSUES in canadian inuit Childbirth and Pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants of Polychlorinated Biphenyls and Methylmercury exposure in inuit women of Childbearing age (50)maternalhealth care, policy, Human resources; interventions/programmingthe outcome of Perinatal Care in inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, Human resources; Birth outcomesthe inuulitsivik maternities: culturally appropriate midwifery and epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection and Cervical lesions in aboriginal women in nunavut, canada (94)maternalchronic disease; social determinants of health; tobacco; mental health and Wellbeingthe health of cree, inuit and southern quebec women: similarities and differences (79)maternalnutrition; social DETERMINANTS of health; environment/environmental exposuresfood insecurity among inuit women exacerbated by socioeconomic stresses and climate change (60)children; youthchronic diseasethe RELATIONSHIP between socio-economic and geographic factors and asthma among canada's aboriginal populations (81)children; youthinfectious diseasehospitalization due to pneumonia among innu, inuit and non-aboriginal communities, newfoundland and labrador, canada (24)children; maternalbirth outcomesheart defects and other malformations in the inuit in canada: a baseline study (62)children; maternalbirth outcomesbirth outcomes in the inuit-inhabited areas of canada (95)children; maternalbirth outcomesdegree of rural isolation and Birth outcomes (63)children; maternalbirth outcomesrisks of adverse Pregnancy outcomes among inuit and north american indian women in quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure to Methylmercury and Pcbs AFFECTS distinct stages of information processing: an event-related POTENTIAL study with inuit children (44)children; maternalenvironment/environmental exposuresthe RELATION of lead neurotoxicity to the event-related potential p3b component in inuit children from arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels of Pregnant inuit women and their infants exposed to environmental contaminants (96)children; maternalenvironment/environmental exposuresneuromotor functions in inuit preschool children exposed to Pb, Pcbs, and hg (43)children; maternalenvironment/environmental exposuresbeneficial EFFECTS of a polyunsaturated Fatty Acid on infant development: EVIDENCE from the inuit of arctic quebec (52)children; maternalenvironment/environmental exposuresthe RELATION of environmental contaminants exposure to behavioural indicators in inuit preschoolers in arctic quebec (46)children; maternalinfectious diseaseneonatal Vitamin A deficiency and its IMPACT on acute Respiratory infections among preschool inuit children (33)children; maternalnutritionanaemia and iron status in inuit infants from northern quebec (97)children; maternalbirth outcomes; nutritioncongenital Heart defects in canadian inuit: is more Folic Acid making a difference?""]"	[('SUPERFICIAL_RELATIONSHIP', 209), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1581), ('IMPORTANT_CONSIDERATION', 2342), ('SUPERFICIAL_RELATIONSHIP', 3334), ('IMPORTANT_CONSIDERATION', 3635), ('IMPORTANT_CONSIDERATION', 3644), ('SUPERFICIAL_RELATIONSHIP', 4527), ('SUPERFICIAL_RELATIONSHIP', 4715), ('SUPERFICIAL_RELATIONSHIP', 5499), ('INCOMPLETE_EVIDENCE', 5567), ('SUPERFICIAL_RELATIONSHIP', 5664), ('SUPERFICIAL_RELATIONSHIP', 6139), ('INCOMPLETE_EVIDENCE', 6202), ('SUPERFICIAL_RELATIONSHIP', 6304), ('SUPERFICIAL_RELATIONSHIP', 6495), ('EXPLICIT_QUESTION', 6787)]	18	[('UBERON_0004905', 'articulation', 110, 'lower respiratory tract'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 451, 'D'), ('CHEBI_27300', 'vitamin D', 502, 'vitamin D'), ('GO_0007565', 'female pregnancy', 596, 'prenatal'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 617, 'polychlorinated biphenyls'), ('UBERON_0001004', 'respiratory system', 665, 'respiratory'), ('UBERON_0004905', 'articulation', 1113, 'lower respiratory tract'), ('UBERON_0001004', 'respiratory system', 1272, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 1447, 'human'), ('UBERON_0000104', 'life cycle', 1613, 'life'), ('GO_0007605', 'sensory perception of sound', 1714, 'hearing'), ('CHEBI_27300', 'vitamin D', 1952, 'vitamin A'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 2429, 'sexually transmitted'), ('GO_0007567', 'parturition', 2689, 'birth'), ('UBERON_0002331', 'umbilical cord', 2855, 'umbilical cord'), ('UBERON_0000178', 'blood', 2870, 'blood'), ('UBERON_0001969', 'blood plasma', 2876, 'plasma'), ('GO_0007565', 'female pregnancy', 3119, 'pregnancy'), ('GO_0007595', 'lactation', 3133, 'lactation'), ('CHEBI_33290', 'food', 3212, 'foods'), ('GO_0007565', 'female pregnancy', 3314, 'prenatal'), ('GO_0007565', 'female pregnancy', 3361, 'pregnancy'), ('GO_0007631', 'feeding behavior', 3477, 'consumption'), ('UBERON_0000178', 'blood', 3493, 'blood'), ('CHEBI_18059', 'lipid', 3499, 'lipids'), ('NCBITaxon_9606', 'Homo sapiens', 3577, 'human'), ('GO_0007567', 'parturition', 3594, 'birth'), ('GO_0007623', 'circadian rhythm', 3669, 'childbirth'), ('GO_0007565', 'female pregnancy', 3684, 'pregnancy'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 3768, 'polychlorinated biphenyls'), ('CHEBI_33963', 'metallocene', 3798, 'methylmercury'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 3839, 'childbearing'), ('NCBITaxon_9606', 'Homo sapiens', 3889, 'human'), ('GO_0036356', 'cyclic 2,3-diphosphoglycerate synthetase activity', 3946, 'perinatal care'), ('UBERON_0012101', 'perinatal stage', 3946, 'perinatal'), ('NCBITaxon_9606', 'Homo sapiens', 4033, 'human'), ('GO_0007567', 'parturition', 4050, 'birth'), ('UBERON_0005434', 'cervical region', 4263, 'cervical'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 4406, 'wellbeingThe'), ('GO_0007567', 'parturition', 5248, 'birth'), ('GO_0007565', 'female pregnancy', 5316, 'pregnancy'), ('CHEBI_33963', 'metallocene', 5476, 'methylmercury'), ('CHEBI_26199', 'polyprenol', 5494, 'PCBs'), ('GO_0007565', 'female pregnancy', 5860, 'pregnant'), ('CHEBI_37983', 'sulfur-35 atom', 6054, 'Pb'), ('CHEBI_26199', 'polyprenol', 6058, 'PCBs'), ('CHEBI_35366', 'fatty acid', 6168, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 6466, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 6511, 'respiratory'), ('UBERON_0000948', 'heart', 6716, 'heart'), ('CHEBI_30751', 'formic acid', 6757, 'folic acid')]
S21-PMC3427192	PMC3427192	4/2012	S21-PMC3427192	['INSTEAD, a number of environmental exposures MAY also alter the rate of Asthma Development.50-54of these modifiable environmental exposures, the ROLE of diet in asthma is of PARTICULAR INTEREST13,55since RECENT STUDIES SUGGEST that the Development Of Asthma in children MAY BE DUE to in utero exposure to Nutrients from the mother’s diet.56given the ROLE of Vitamin D in inflammation and Immunomodulation, SEVERAL STUDIES have focused on in utero Vitamin D exposure and subsequent asthma in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 174), ('ANOMALY_CURIOUS_FINDING', 185), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 219), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 277), ('SUPERFICIAL_RELATIONSHIP', 350), ('INCOMPLETE_EVIDENCE', 406)]	11	[('GO_0035801', 'adrenal cortex development', 72, 'asthma development'), ('GO_0009602', 'detection of symbiont', 236, 'development of asthma'), ('CHEBI_33284', 'nutrient', 305, 'nutrients'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 388, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 447, 'vitamin D')]
S38-PMC3427192	PMC3427192	4/2012	S38-PMC3427192	['due to higher levels of Melanin, african americans have the highest prevalence of Vitamin D deficiency, with the highest prevalence in those living in urban environments.43,76at the same time, asthma is also more PREVALENT in african american children.10,11only ONE STUDY TO DATE has FOCUSED on Vitamin D status in school-aged african american asthmatic children.']	[('IMPORTANT_CONSIDERATION', 213), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 272), ('QUESTION_ANSWERED_BY_THIS_WORK', 284)]	4	[('CHEBI_25179', 'melanins', 24, 'melanin'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
S66-PMC3427192	PMC3427192	4/2012	S66-PMC3427192	['in ONE STUDY, modest ASSOCIATIONS were NOTED between several Genes in the Vitamin D pathway and asthma and allergic sensitization in populations enriched for subjects with current asthma.86a separate study of asthmatics also FOUND Haplotype ASSOCIATIONS for Cyp24A1 , the primary enzyme ASSOCIATED with Calcidiol Metabolism, where a 5-point Haplotype was ASSOCIATED with asthma, allergic sensitization, and Vitamin D Metabolites in asthmatic subjects.92while these PRELIMINARY results SUGGEST that Genetic components MAY account for Vitamin D status in subjects with asthma, OTHER STUDIES ARE NEEDED to determine tease out the Genetic vs. environmental UNDERPINNINGS of Vitamin D status in this population.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 39), ('INCOMPLETE_EVIDENCE', 225), ('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 287), ('SUPERFICIAL_RELATIONSHIP', 355), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 485), ('INCOMPLETE_EVIDENCE', 517), ('FUTURE_WORK', 575), ('FUTURE_WORK', 581), ('SUPERFICIAL_RELATIONSHIP', 653)]	13	[('SO_0000704', 'gene', 61, 'genes'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('SO_0001024', 'haplotype', 231, 'haplotype'), ('PR_000006101', 'cytochrome P450 1A1', 258, 'CYP24A1'), ('CHEBI_17933', 'calcidiol', 303, 'calcidiol'), ('GO_0008152', 'metabolic process', 313, 'metabolism'), ('SO_0001024', 'haplotype', 341, 'haplotype'), ('CHEBI_27300', 'vitamin D', 407, 'vitamin D'), ('CHEBI_25212', 'metabolite', 417, 'metabolites'), ('SO_0000704', 'gene', 498, 'genetic'), ('CHEBI_27300', 'vitamin D', 533, 'vitamin D'), ('SO_0000704', 'gene', 627, 'genetic'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D')]
S11-PMC3472720	PMC3472720	8/2012	S11-PMC3472720	['this season of Birth EFFECT, combined with an OBSERVED latitude gradient in incidence (higher risk at higher latitude) [10], SUGGEST that an environmental FACTOR, POSSIBLY Vitamin D exposure, MAY BE IMPORTANT in PREDICTING ms risk.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 192), ('IMPORTANT_CONSIDERATION', 199), ('SUPERFICIAL_RELATIONSHIP', 212)]	8	[('GO_0007567', 'parturition', 15, 'birth'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
S110-PMC3472720	PMC3472720	8/2012	S110-PMC3472720	['IN LINE WITH our Animal study, we predicted that parents developing in a Vitamin D poor environment during the third Trimester of Pregnancy, in other words those born in spring, will be at higher risk of Giving Birth to ms Individuals.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('NCBITaxon_33208', 'Metazoa', 17, 'animal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 117, 'trimester'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('GO_0040007', 'growth', 204, 'giving'), ('GO_0007567', 'parturition', 211, 'birth'), ('NCBITaxon_1', 'root', 223, 'individuals')]
S112-PMC3472720	PMC3472720	8/2012	S112-PMC3472720	['HOWEVER, we FOUND that parents developing in a supposedly Vitamin D rich environment ( i.e.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
S0-PMC3476426	PMC3476426	8/2012	S0-PMC3476426	['reduced Serum concentrations of 25-Hydroxy Vitamin D in children with autism: RELATION to autoimmunity\n\nabstract\n\nbackground\naside from the Skeletal health affection, Vitamin D deficiency has BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering for SOME Autoimmune disorders.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ANOMALY_CURIOUS_FINDING', 192), ('SUPERFICIAL_RELATIONSHIP', 197), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 237), ('INCOMPLETE_EVIDENCE', 259)]	6	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 32, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0004288', 'skeleton', 140, 'skeletal'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 264, 'autoimmune')]
S22-PMC3476426	PMC3476426	8/2012	S22-PMC3476426	['RECENTLY, Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders, including multiple sclerosis (ms) and systemic lupus erythematosus (sle) [5-7].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 103, 'autoimmune')]
S91-PMC3476426	PMC3476426	8/2012	S91-PMC3476426	['RECENTLY, Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders [5,6].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 103, 'autoimmune')]
S128-PMC3476426	PMC3476426	8/2012	S128-PMC3476426	['Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders SUGGESTING that Vitamin D MIGHT play a ROLE in Regulating auto-Antibody production [5,6].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 153)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001442', 'skeleton of manus', 93, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0065007', 'biological regulation', 161, 'regulating'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibody')]
S222-PMC3501517	PMC3501517	11/2012	S222-PMC3501517	['additionally, in the prior study, the breeders were Vitamin D deficient; WHEREAS, ours were only placed in a Vitamin deficient environment once they were already visibly Pregnant.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 73)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 109, 'vitamin'), ('GO_0007565', 'female pregnancy', 170, 'pregnant')]
S3-PMC3635901	PMC3635901	4/2013	S3-PMC3635901	['within the environmental FACTORS generating autoimmunity are now included unsuspected Molecules such as Vitamin D and aluminum.']	[('SUPERFICIAL_RELATIONSHIP', 25)]	1	[('CHEBI_36357', 'polyatomic entity', 86, 'molecules'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
S106-PMC3659910	PMC3659910	1/2013	S106-PMC3659910	['induction of the 1α-hydroxylase in early Gestation MIGHT provide a mechanism by which environmental or dietary Vitamin D CAN INFLUENCE fetal-Placental Development.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 125)]	3	[('GO_0007565', 'female pregnancy', 41, 'gestation'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0001890', 'placenta development', 141, 'placental development'), ('UBERON_0001987', 'placenta', 141, 'placental')]
S2-PMC3668200	PMC3668200	5/2013	S2-PMC3668200	['many Genetic, dietary, and environmental FACTORS AFFECT the body concentration of Vitamin D, Calcium, Phosphorus, and Bone Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('SO_0000704', 'gene', 5, 'genetic'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 93, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 102, 'phosphorus'), ('GO_0007567', 'parturition', 118, 'bone'), ('GO_0008152', 'metabolic process', 123, 'metabolism')]
S52-PMC3668200	PMC3668200	5/2013	S52-PMC3668200	['Vitamin D concentration is AFFECTED by many Genetic, dietary, and environmental FACTORS; THEREFORE, it is RECOMMENDED that researchers CONSIDER the relative and EFFECTIVE FACTORS when performing STUDIES concerning Vitamin D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 80), ('PROBABLE_UNDERSTANDING', 89), ('FUTURE_WORK', 106), ('FUTURE_WORK', 135), ('SUPERFICIAL_RELATIONSHIP', 161), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 195)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('SO_0000704', 'gene', 44, 'genetic'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
S92-PMC3672018	PMC3672018	5/2013	S92-PMC3672018	['exposure assessment\nfour main analyses of exposure related to initiation and termination of Vitamin D fortification will be considered for each of the disease outcomes:\n1. Perinatal exposure to Vitamin D for offspring;\n2. seasonal variation in Vitamin D exposure in different Pregnancy trimesters;\n3. exposure to Vitamin D adjusted for Genetic and common environmental INFLUENCES;\n4. levels of Vitamin D (25(Oh)D3) measured in infant Blood from dbs cards.']	[('SUPERFICIAL_RELATIONSHIP', 369)]	1	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0036268', 'swimming', 172, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 172, 'perinatal'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D'), ('SO_0000704', 'gene', 336, 'genetic'), ('CHEBI_27300', 'vitamin D', 394, 'vitamin D'), ('CHEBI_62946', 'ammonium sulfate', 405, '25(OH)D3'), ('UBERON_0000178', 'blood', 434, 'blood')]
S72-PMC3702245	PMC3702245	6/2013	S72-PMC3702245	['the institute of MEDICINE7CONSIDERS a Serum 25(Oh)D concentration >50 nmol/l AS acceptable, WHILE the Endocrine society and Vitamin D EXPERTS RECOMMEND >75 nmol/l.8,99a RECENT STUDY among traditional populations in tanzania with type vi (dark) skin color living in a sun-abundant environment RECOMMENDED a mean Serum 25(Oh)D concentration of 115 nmol/l in nonpregnant Adults and 139 nmol/l in Pregnant women.57the question then is: WHAT Serum concentration of 25(Oh)D is “normal” in Adults, including during Pregnancy?']	[('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 134), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 169), ('FUTURE_WORK', 292), ('EXPLICIT_QUESTION', 432), ('EXPLICIT_QUESTION', 517)]	9	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 44, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 102, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'serum'), ('CHEBI_71657', 'versiconol acetate', 317, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 317, '25(OH)D'), ('UBERON_0007023', 'adult organism', 368, 'adults'), ('GO_0007565', 'female pregnancy', 393, 'pregnant'), ('UBERON_0001977', 'blood serum', 437, 'serum'), ('CHEBI_71657', 'versiconol acetate', 460, '25(OH)D'), ('UBERON_0007023', 'adult organism', 483, 'adults'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy')]
S73-PMC3702245	PMC3702245	6/2013	S73-PMC3702245	['WHILE the DEBATE and studies to identify OPTIMAL Serum 25(Oh)D concentration CONTINUE, it is PRUDENT to monitor Vitamin D status and develop STRATEGIES to ensure AT LEAST a minimum Serum 25(Oh)D concentration of 50 nmol/l in Pregnant women, especially in an environment where Vitamin D deficiency is endemic.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 77), ('FUTURE_WORK', 93), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_WORK', 141), ('PROBABLE_UNDERSTANDING', 162)]	8	[('UBERON_0001977', 'blood serum', 49, 'serum'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 55, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001977', 'blood serum', 181, 'serum'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 187, '25(OH)D'), ('GO_0007565', 'female pregnancy', 225, 'pregnant'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D')]
S221-PMC3705146	PMC3705146	5/2013	S221-PMC3705146	['in such a manner, certain polymorphisms in melanotropin Genes MAY have become more prevalent in low-light environments IF they positively AFFECTED the natural Synthesis Of Vitamin D by reducing the Synthesis and Sequestration Of Melanin (valverde et al.,1995).']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('SO_0000704', 'gene', 56, 'genes'), ('GO_0030474', 'spindle pole body duplication', 159, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 198, 'synthesis'), ('GO_0098725', 'symmetric cell division', 212, 'sequestration of melanin'), ('CHEBI_25179', 'melanins', 229, 'melanin')]
S262-PMC3705146	PMC3705146	5/2013	S262-PMC3705146	['the need for Vitamin D MAY have AFFECTED NOT ONLY Gene frequencies of relevance to schizophrenia BUT MAY ALSO have Modulated Gene-environment INTERACTIONS that CAN occur in differing light regimes.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 32), ('ANOMALY_CURIOUS_FINDING', 41), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 101), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 160)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('SO_0000704', 'gene', 50, 'gene'), ('GO_0065007', 'biological regulation', 115, 'modulated'), ('SO_0000704', 'gene', 125, 'gene')]
S46-PMC3713405	PMC3713405	7/2013	S46-PMC3713405	['GIVEN that Vitamin D deficiency is common (1) during winter and spring, (2) at high latitudes (holick et al., 1995), (3) in urban environments (mcgrath et al., 2001) and (4) in dark skinned Individuals (clemens et al., 1982;holick et al., 1995), these ecological data led TO the HYPOTHESIS that low maternal Vitamin D COULD BE a modified risk FACTOR for schizophrenia.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 272), ('INCOMPLETE_EVIDENCE', 279), ('INCOMPLETE_EVIDENCE', 318), ('SUPERFICIAL_RELATIONSHIP', 343)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 190, 'individuals'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]
S106-PMC3773018	PMC3773018	4/2013	S106-PMC3773018	['the extent of Vitamin D insufficiency in this process MAY BE UNDERESTIMATED by a static, single value, and emphasizes that longer term exposure to a Vitamin D deficient state MIGHT have profound health consequences in a specific Genetic environment.']	[('INCOMPLETE_EVIDENCE', 54), ('PROBLEM_COMPLICATION', 61), ('INCOMPLETE_EVIDENCE', 175)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('SO_0000704', 'gene', 229, 'genetic')]
S47-PMC3814422	PMC3814422	10/2013	S47-PMC3814422	['potential confounders and mediators\nwe considered the following as POTENTIAL CONFOUNDERS BECAUSE of their KNOWN or POTENTIAL PLAUSIBLE ASSOCIATION with both maternal concentrations of Vitamin D and with childhood atopic and Lung function outcomes21,22: maternal FACTORS during Pregnancy [smoking, infections, anxiety score, Antibiotic use, Paracetamol use, body mass index (bmi) and Alcohol intake], OTHER maternal factors (educational level, housing tenure, financial difficulties, ethnicity, age, parity, history of asthma, eczema, rhinoconjunctivitis, migraine) and Postnatal FACTORS that MAY reflect a background socio-economic CONFOUNDING pathway originating prior to Birth (breastfeeding, day care, pets, exposure to damp/mould in home, environmental tobacco smoke exposure and number of younger siblings).']	[('INCOMPLETE_EVIDENCE', 67), ('PROBLEM_COMPLICATION', 77), ('PROBLEM_COMPLICATION', 89), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 135), ('SUPERFICIAL_RELATIONSHIP', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 400), ('SUPERFICIAL_RELATIONSHIP', 579), ('INCOMPLETE_EVIDENCE', 592), ('PROBLEM_COMPLICATION', 632)]	12	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0002048', 'lung', 224, 'lung'), ('GO_0007565', 'female pregnancy', 277, 'pregnancy'), ('CHEBI_33282', 'antibacterial agent', 324, 'antibiotic'), ('CHEBI_46195', 'paracetamol', 340, 'paracetamol'), ('CHEBI_30879', 'alcohol', 383, 'alcohol'), ('GO_0007567', 'parturition', 569, 'postnatal'), ('GO_0007567', 'parturition', 673, 'birth')]
S1-PMC4045304	PMC4045304	2/2014	S1-PMC4045304	['though both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.']	[('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 174), ('SUPERFICIAL_RELATIONSHIP', 182), ('INCOMPLETE_EVIDENCE', 254)]	7	[('SO_0000704', 'gene', 12, 'genetic'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_30751', 'formic acid', 214, 'folic acid'), ('GO_0008152', 'metabolic process', 230, 'metabolic')]
S22-PMC4072587	PMC4072587	6/2014	S22-PMC4072587	['more RECENTLY, maternal Vitamin D deficiency HAS BEEN ASSOCIATED with impaired infant Language Development in school-aged children[24], and HAS BEEN SUGGESTED as a possible environmental risk FACTOR for autism spectrum disorder, HIGHLIGHTING the IMPORTANT ROLE of Vitamin D in Brain Development, Neuronal function and Gene Regulation[10],[25],[26].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 229), ('IMPORTANT_CONSIDERATION', 246), ('SUPERFICIAL_RELATIONSHIP', 256)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0060132', 'prolactin secreting cell development', 86, 'language development'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D'), ('GO_0007420', 'brain development', 277, 'brain development'), ('UBERON_0000955', 'brain', 277, 'brain'), ('CL_0000540', 'neuron', 296, 'neuronal'), ('SO_0000704', 'gene', 318, 'gene'), ('GO_0065007', 'biological regulation', 323, 'regulation')]
S124-PMC4072587	PMC4072587	6/2014	S124-PMC4072587	['RECENT RESEARCH SUGGESTS that Vitamin D deficiency during Pregnancy or early childhood MAY BE an environmental TRIGGER for autism spectrum disorder in infants Genetically predisposed to autism, EITHER through its EFFECT on Neuronal function and Brain Development, or through Gene interaction and Regulation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('SUPERFICIAL_RELATIONSHIP', 213)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('SO_0000704', 'gene', 159, 'genetically'), ('CL_0000540', 'neuron', 223, 'neuronal'), ('GO_0007420', 'brain development', 245, 'brain development'), ('UBERON_0000955', 'brain', 245, 'brain'), ('SO_0000704', 'gene', 275, 'gene'), ('GO_0065007', 'biological regulation', 296, 'regulation')]
S153-PMC4072587	PMC4072587	6/2014	S153-PMC4072587	['HOWEVER, SIMILAR FINDINGS in PREVIOUS STUDIES[24],[38],[41],[42],[43]and the INCREASING EVIDENCE for Vitamin D deficiency AS a POTENTIAL environmental risk FACTOR for autism[10],[25],[26]SUGGEST that these ASSOCIATIONS SHOULD NOT BE discounted.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 122), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 206), ('FUTURE_WORK', 219)]	10	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
S963-PMC4113768	PMC4113768	7/2014	S963-PMC4113768	['logistic regression was used TO IDENTIFY environmental and Genetic factors independently ASSOCIATED with risk of Vitamin D deficiency DEFINED as Serum 25(Oh)D concentration <50 nmol/l.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('SUPERFICIAL_RELATIONSHIP', 89), ('PROBABLE_UNDERSTANDING', 134)]	3	[('SO_0000704', 'gene', 59, 'genetic'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 151, '25(OH ... D')]
S2563-PMC4113768	PMC4113768	7/2014	S2563-PMC4113768	['we AIMED TO EXAMINE the environmental and Genetic DETERMINANTS of change in 25 Hydroxy Vitamin D (25(Oh)D).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('SO_0000704', 'gene', 42, 'genetic'), ('CHEBI_45557', 'sec-butyl group', 76, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D')]
S139-PMC4251419	PMC4251419	12/2014	S139-PMC4251419	['Genetic variation in the physiological response to Vitamin D supplementation\na high degree of Individual VARIABILITY in the 25(Oh)D response to Vitamin D supplementation has been DESCRIBED that is the result of demographic, environmental and Genetic FACTORS [79].']	[('DIFFICULT_TASK', 105), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 250)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_1', 'root', 94, 'individual'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('SO_0000704', 'gene', 242, 'genetic')]
S38-PMC4377879	PMC4377879	3/2015	S38-PMC4377879	['a systematic review identifying all studies that had been published between 1988 and 2008 reporting on Micronutrient intakes in women living in such environments, SHOWED that for women, the REPORTED mean/median intakes in over 50% of the studies were below the estimated average requirements (ear) for Micronutrient intakes, except for Vitamin a, Vitamin C, and niacin, where the reported intakes were around a third of the ear, 29%, 34% and 34% respectively [11].']	[('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 190)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 103, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 302, 'micronutrient'), ('CHEBI_33229', 'vitamin (role)', 336, 'vitamin'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin C')]
S121-PMC4396835	PMC4396835	1/2015	S121-PMC4396835	['the study - TO OUR KNOWLEDGE - is the FIRST in which Vitamin D levels in dried Blood Spots, from the Newborn Period, HAVE BEEN analysed in samples of children with asd and in their non-asd siblings, thereby controlling for shared environmental and Genetic causes for asd.']	[('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 117)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 79, 'blood spots'), ('UBERON_0007221', 'neonate stage', 101, 'newborn period'), ('SO_0000704', 'gene', 248, 'genetic')]
S184-PMC4438628	PMC4438628	5/2015	S184-PMC4438628	['Human and/or experimental research SHOWS that acute and cumulative psychological stress (and ASSOCIATED MARKERS of Allostatic load) [273-276], environmental Pollutants [277-282], crowding [283], acoustic stress [284], heat stress [285], westernized dietary patterns [286], high Fructose and Sodium [287], dietary Age and Food Additives via processed foods [288,289], lack of colorful dietary Phytochemicals [290,291], magnesium deficiency [292], inadequate omega-3 [293], Antibiotic administration [294], excess Alcohol consumption [295,296], the Oral periodontopathogen p. gingivalis (when Swallowed) [297], tobacco exposure [298,299], sedentary behavior [300], Circadian disruptions [301], Sleep problems with functional constipation [302], and low levels of Vitamin D [303,304] are each individually ASSOCIATED with marked shifts in the Intestinal microbiota.']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 803)]	4	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('GO_0007565', 'female pregnancy', 115, 'allostatic'), ('CHEBI_26199', 'polyprenol', 157, 'pollutants'), ('CHEBI_28757', 'fructose', 278, 'fructose'), ('CHEBI_52632', 'potassium-39 atom', 291, 'sodium'), ('CHEBI_80551', 'APC', 313, 'AGE'), ('CHEBI_77968', 'humectant', 321, 'food additives'), ('CHEBI_26254', 'prenylnaphthoquinone', 392, 'phytochemicals'), ('CHEBI_33282', 'antibacterial agent', 472, 'antibiotic'), ('CHEBI_30879', 'alcohol', 512, 'alcohol'), ('UBERON_0000165', 'mouth', 547, 'oral'), ('GO_0035196', 'production of miRNAs involved in gene silencing by miRNA', 591, 'swallowed'), ('GO_0051216', 'cartilage development', 663, 'circadian'), ('GO_0030431', 'sleep', 692, 'sleep'), ('CHEBI_27300', 'vitamin D', 761, 'vitamin D'), ('UBERON_0000160', 'intestine', 840, 'intestinal')]
S190-PMC4438628	PMC4438628	5/2015	S190-PMC4438628	['psychological stress\nprocessed and ultra-processed Foods\nFood Additives\nAdvanced Glycation End Products (Ages)\nabsence of Phytochemicals\ninadequate essential Fats\ninadequate Vitamin D\ninadequate magnesium\nAntibiotic administration\npotentially pathogenic Oral bacteria\nlack of physical activity/excess indoor screen time\ntobacco use\nAlcohol use\nsleep problems/Circadian disruptions\ncrowding\nclimatic stress\nenvironmental Toxins\n\nsummary and future directions\nDESPITE its obvious ripple into so many aspects of societal health, the ‘no health without mental health’ dictum is OFTEN afforded only lip service by funding bodies [309].']	[('ANOMALY_CURIOUS_FINDING', 458), ('PROBABLE_UNDERSTANDING', 574)]	2	[('CHEBI_33290', 'food', 51, 'foods'), ('CHEBI_78601', '11,21-dioxoprogesterone', 57, 'Food additives'), ('GO_0006116', 'NADH oxidation', 72, 'Advanced glycation'), ('CHEBI_46678', 'amosite asbestos', 81, 'glycation end products'), ('CHEBI_74913', 'AOPE', 105, 'AGEs'), ('CHEBI_26254', 'prenylnaphthoquinone', 122, 'phytochemicals'), ('CHEBI_33250', 'atom', 158, 'fats'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_33282', 'antibacterial agent', 205, 'Antibiotic'), ('UBERON_0000165', 'mouth', 254, 'oral'), ('CHEBI_30879', 'alcohol', 332, 'Alcohol'), ('GO_0051216', 'cartilage development', 359, 'circadian'), ('CHEBI_27026', 'toxin', 420, 'toxins')]
S468-PMC4448820	PMC4448820	5/2015	S468-PMC4448820	['last, compartmentalization of Nutrients during inflammation MAY create a permissive environment for inflammation to occur via temporary removal of Nutrients (e.g., Vitamin A, zinc) that negatively regulate Nf-Κb activity (118,126).']	[('INCOMPLETE_EVIDENCE', 60)]	1	[('CHEBI_33284', 'nutrient', 30, 'nutrients'), ('CHEBI_33284', 'nutrient', 147, 'nutrients'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A'), ('GO_0005883', 'neurofilament', 206, 'NF-'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 206, 'NF-κB')]
S471-PMC4448820	PMC4448820	5/2015	S471-PMC4448820	['ALTHOUGH Vitamin A is absolutely REQUIRED for mounting an effective Immune Response, it is TEMPTING to SPECULATE that temporarily inhibiting Plasma Delivery Of Vitamin A to Tissues is beneficial to the host by creating a favorable environment for inflammation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 103)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0006955', 'immune response', 68, 'immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('GO_0070983', 'dendrite guidance', 148, 'delivery of vitamin A'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin A'), ('UBERON_0000479', 'tissue', 173, 'tissues')]
S13-PMC4452099	PMC4452099	6/2015	S13-PMC4452099	['a variety of environmental t1d risk and PROTECTIVE FACTORS, including Vitamin D supplementation during Gestation and in early infancy, HAVE BEEN investigated [5–9].']	[('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 135)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'gestation')]
S93-PMC4466139	PMC4466139	6/2015	S93-PMC4466139	['THESE STUDIES EVEN IF LIMITED to specific populations (caucasians [28], arab an asian [29], rural populations of south china [30]) SHOW a COMPLEX picture of Genetic FACTORS determining the level of 25Ohd and consequent risks of deficiency of Vitamin D. DESPITE this, the environmental COMPONENT is STILL preponderant ALTHOUGH LIMITED to 57–71% in determining the level of 25Ohd.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 131), ('DIFFICULT_TASK', 138), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253), ('ANOMALY_CURIOUS_FINDING', 253), ('SUPERFICIAL_RELATIONSHIP', 285), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 326)]	13	"[('SO_0000704', 'gene', 157, 'genetic'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 198, '25OHD'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 372, '25OHD')]"
S36-PMC4488777	PMC4488777	5/2015	S36-PMC4488777	['an OPTIMAL level of Vitamin D concentration in Blood Serum SHOULD range between 50 and 125 nmol/l [10], EVEN THOUGH SOME environmental STUDIES IMPLY that the target level SHOULD BE set much higher—up to 250, or even at 300 nmol/l [11,12].']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 59), ('ANOMALY_CURIOUS_FINDING', 104), ('INCOMPLETE_EVIDENCE', 116), ('PROBABLE_UNDERSTANDING', 143), ('IMPORTANT_CONSIDERATION', 171)]	6	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0001977', 'blood serum', 53, 'serum')]
S48-PMC4499946	PMC4499946	7/2015	S48-PMC4499946	['clinical, biochemical, and microbiological Surveillance of enrolled mother-infant pairs will enable a range of secondary objectives to be addressed, including (1) estimation of the EFFECT of maternal Vitamin D supplementation on the incidence of acute Respiratory infections (aris) during early infancy; (2) exploration of the ROLES of specific hormones, Nutrients, environmental Contaminants, and inflammatory markers in the mediation or modification of the EFFECT of Vitamin D on fetal and infant growth, with particular emphasis on the ROLE of the Parathyroid hormone (pth) system; and (3) investigation of the ROLE of epigenetic modification of Genes involved in Perinatal Vitamin D Metabolism in infant stunting.']	[('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 327), ('SUPERFICIAL_RELATIONSHIP', 459), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 614)]	5	[('GO_0065007', 'biological regulation', 43, 'surveillance'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 252, 'respiratory'), ('CHEBI_33284', 'nutrient', 355, 'nutrients'), ('CHEBI_60688', 'EC 4.2.1.20 (tryptophan synthase) inhibitor', 380, 'contaminants'), ('CHEBI_27300', 'vitamin D', 469, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 551, 'parathyroid'), ('SO_0000704', 'gene', 649, 'genes'), ('GO_0036268', 'swimming', 667, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 667, 'perinatal'), ('CHEBI_27300', 'vitamin D', 677, 'vitamin D'), ('GO_0008152', 'metabolic process', 687, 'metabolism')]
S15-PMC4595656	PMC4595656	10/2015	S15-PMC4595656	['the increased demands of the developing fetus combined with a POSSIBLE decrease in environmental exposure to sunlight, MAY result in diminished circulating Vitamin D (hillman and haddad,1976; markestad et al.,1983).']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 119)]	2	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
S2-PMC4605923	PMC4605923	11/2015	S2-PMC4605923	['Food intake is a WELL-known environmental FACTOR that INFLUENCES Allergy Development and three specific Nutrients-Vitamin D, Omega 3 polyunsaturated Fatty Acids and Folate-have RECENTLY attracted ATTENTION.1\nthe methyl donor Folate is a WELL-KNOWN Nutrient supplement given during early Pregnancy to prevent neutral Tube defects in the developing fetus.']	[('PROBABLE_UNDERSTANDING', 17), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 177), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 237)]	6	"[('CHEBI_33290', 'food', 0, 'Food'), ('GO_0060021', 'roof of mouth development', 65, 'allergy development'), ('CHEBI_33284', 'nutrient', 104, 'nutrients'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_82673', ""2-amino-6,7-dimethyl-4-oxo-8-(1'-D-ribityl)-4,8-dihydropteridine"", 125, 'omega 3'), ('CHEBI_35366', 'fatty acid', 149, 'fatty acids'), ('CHEBI_30863', '5-azaorotic acid', 165, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 225, 'folate'), ('CHEBI_33284', 'nutrient', 248, 'nutrient'), ('GO_0007565', 'female pregnancy', 287, 'pregnancy'), ('UBERON_0000025', 'tube', 316, 'tube')]"
S96-PMC4624803	PMC4624803	10/2015	S96-PMC4624803	['from a THEORETICAL POINT OF VIEW, in foetal Life and during early childhood, the immature Brain SHOULD BE more vulnerable to environmental INFLUENCES like Vitamin D deficiency [3,4].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0000955', 'brain', 90, 'brain'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
S69-PMC4691762	PMC4691762	12/2015	S69-PMC4691762	"[""participant's Vitamin D status will be defined by their Blood 25Ohd3 level, AS: severely deficient <12.5\u2005nmol/l; moderately deficient 12.5–25\u2005nmol/l; mild deficiency 26–49\u2005nmol/l; sufficient ≥50\u2005nmol/l; and elevated >220\u2005nmol/l.23\nparent baseline questionnaire : to check that potential environmental and OTHER CONFOUNDING factors are balanced between the two randomisation groups, baseline parent questionnaires will collect data on: parental smoking, medication use, parental ancestry, ethnicity, education, employment, occupation, family history of allergy, use of supplements including Vitamin A, d and cod Liver oil, number of siblings; and pet ownership.""]"	[('PROBABLE_UNDERSTANDING', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 305), ('PROBLEM_COMPLICATION', 311)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000178', 'blood', 56, 'blood'), ('CHEBI_63058', '(2R,3S)-EHNA', 62, '25OHD3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 62, '25OHD3'), ('CHEBI_27300', 'vitamin D', 590, 'vitamin A'), ('UBERON_0002107', 'liver', 611, 'liver')]
S70-PMC4691762	PMC4691762	12/2015	S70-PMC4691762	['parent questionnaire (3 monthly) : to capture dietary Vitamin D intake and environmental uv radiation (uvr) exposure, we will ask questions about maternal Vitamin D supplements, infant diet, maternal and infant sun exposure and sun Protective behaviours as in our PREVIOUS work,15for example, number of hours spent in the sun per day, during summer or winter, weekends and holidays, will be collected for mother and child.']	[('INCOMPLETE_EVIDENCE', 264)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0019230', 'proprioception', 232, 'protective')]
S25-PMC4764019	PMC4764019	1/2016	S25-PMC4764019	['Birth month, in itself, EXHIBITS precisely that RELATIONSHIP.7the UNDERLYING presumption is that the Intrauterine environment would have been relatively deprived of Vitamin D for Births occurring in late spring, and the same environment would have been richer in Vitamin D for births occurring in late fall.']	[('ANOMALY_CURIOUS_FINDING', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('GO_0007567', 'parturition', 0, 'Birth'), ('UBERON_0022293', 'reproductive gland secretion', 101, 'intrauterine'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007567', 'parturition', 179, 'births'), ('CHEBI_27300', 'vitamin D', 263, 'vitamin D')]
S108-PMC4765528	PMC4765528	12/2015	S108-PMC4765528	['the programming effect of an adverse in-utero environment and the role of epigenetics\nIT IS CLEAR that there is a strong Genetic predisposition to osteoporosis and although the Genes that Regulate bone mass have not been COMPLETELY established, responsible Gene variants include Vitamin D receptor polymorphisms [47], Collagen-1 Receptor [48] and Oestrogen receptor variants [49].']	[('PROBABLE_UNDERSTANDING', 86), ('PROBABLE_UNDERSTANDING', 221)]	2	[('SO_0000704', 'gene', 121, 'genetic'), ('SO_0000704', 'gene', 177, 'genes'), ('GO_0065007', 'biological regulation', 188, 'regulate'), ('SO_0000704', 'gene', 257, 'gene'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin D'), ('PR_000003266', 'collagen type II alpha chain', 318, 'collagen-1 receptor'), ('CHEBI_50114', 'estrogen', 347, 'oestrogen')]
S123-PMC4765528	PMC4765528	12/2015	S123-PMC4765528	['studies using the alspac cohort SHOW that Bone Development of the child is clearly RELATED to the in utero environment, BUT that SOME of the ASSOCIATIONS CAN be explained IN PART by the shared ASSOCIATIONS with bone and body size, ALTHOUGH maternal Vitamin D status exerts persisting EFFECTS on bone mass development [19].']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 193), ('ANOMALY_CURIOUS_FINDING', 231), ('SUPERFICIAL_RELATIONSHIP', 284)]	10	[('GO_0048539', 'bone marrow development', 42, 'bone development'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
S61-PMC4784858	PMC4784858	3/2016	S61-PMC4784858	['in this STUDY, the updated pandiet score for the french sample was composed of 27 probabilities of adequacy (protein, total Carbohydrate, dietary fibre, total fat, la, ala, dha, epa+Dha, Vitamin A, Thiamin, riboflavin, Niacin, Pantothenic Acid, Vitamin B6, Folate, Vitamin B12, Vitamin C, Vitamin D, Vitamin E, calcium, Iodine, iron, magnesium, Phosphorus, Potassium, Selenium and zinc) in the as and of seven probabilities of adequacy (protein, total Carbohydrate, Free Sugars, total fat, Saturated Fatty Acids, Cholesterol and Sodium) plus 14 POTENTIAL penalties (Retinol, niacin, Vitamin B6, Folate, Vitamin C, Vitamin D, Vitamin E, Calcium, Iodine, iron, magnesium, Phosphorus, Selenium and zinc) in the ms.\ndietary reference values used to calculate the pandiet for the french sample were those emitted by the french agency for Food, environmental and occupational health (anses), (s1 table) [25,26], except for iron for which the probability of adequacy was determined using values published by the institute of medicine [27,28].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 545)]	2	[('CHEBI_16730', 'chloramphenicol 3-acetate', 124, 'carbohydrate'), ('CHEBI_17874', 'dihydrozeatin', 182, 'DHA'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin A'), ('CHEBI_26948', 'vitamin B1', 198, 'thiamin'), ('CHEBI_7542', 'neurotensin', 219, 'niacin'), ('CHEBI_7916', 'pantothenic acid', 227, 'pantothenic acid'), ('CHEBI_33237', 'vitamin D4', 245, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 257, 'folate'), ('CHEBI_33279', 'vitamin D5', 265, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin E'), ('CHEBI_24859', 'iodine atom', 320, 'iodine'), ('CHEBI_35885', 'secondary phosphine', 345, 'phosphorus'), ('CHEBI_22314', 'alkali metal atom', 357, 'potassium'), ('CHEBI_27568', 'selenium atom', 368, 'selenium'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 452, 'carbohydrate'), ('CHEBI_37958', 'dye', 466, 'free'), ('CHEBI_26822', 'sulfide', 471, 'sugars'), ('CHEBI_26604', 'santonin', 490, 'saturated fatty acids'), ('CHEBI_16113', 'cholesterol', 513, 'cholesterol'), ('CHEBI_52632', 'potassium-39 atom', 529, 'sodium'), ('CHEBI_26536', 'retinoic acid', 566, 'retinol'), ('CHEBI_33237', 'vitamin D4', 583, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 595, 'folate'), ('CHEBI_27300', 'vitamin D', 603, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 614, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 625, 'vitamin E'), ('CHEBI_22313', 'alkaline earth metal atom', 636, 'calcium'), ('CHEBI_24859', 'iodine atom', 645, 'iodine'), ('CHEBI_35885', 'secondary phosphine', 670, 'phosphorus'), ('CHEBI_27568', 'selenium atom', 682, 'selenium'), ('CHEBI_33290', 'food', 833, 'Food')]
S4488-PMC4896250	PMC4896250	4/2016	S4488-PMC4896250	['moreover, the RELATIONSHIP between Serum 25-Oh Vitamin D levels and Pulmonary function test and environmental FACTORS for sunshine were EXAMINED in asthmatic patients.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 110), ('QUESTION_ANSWERED_BY_THIS_WORK', 136)]	3	[('UBERON_0001977', 'blood serum', 35, 'serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 41, '25-OH'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002048', 'lung', 68, 'pulmonary')]
S7049-PMC4896250	PMC4896250	4/2016	S7049-PMC4896250	['a496 the EFFECT of Cord Serum 25-Hydroxyvitamin D (25(Oh)D) on the development of atopic dermatitis in first 3 years of Life : cocoa study\n\nhyun-ju cho1, youn ho shin2, eun lee3, young-ho kim3, darae lee3, mi-jin kang4, song-i yang5, kangmo ahn6, kyung won kim7, yoon hee kim7, hye-sung won3, soo hyun kim2, suk-joo choi6, young han kim7, jong kwan jun8, eun-jin kim9, jeom gyu lee9, so-yeon lee5, soo-jong hong1, dongin suh10\n\n1department of pediatrics, childhood asthma atopy center, environmental health center, asan medical center, university of ulsan college of medicine, south korea;2cha medical center;3asan medical center;4asan institute for Life science, asan medical center;5hallym university sacred Heart hospital;6samsung medical center;7yonsei university college of medicine;8seoul national university college of medicine;9korea national institute of health;10seoul national university hospital\n\ncorrespondence: hyun-ju cho – department of pediatrics, childhood asthma atopy center, environmental health center, asan medical center, university of ulsan college of medicine, south korea\nbackground: the ASSOCIATION between Serum Vitamin D deficiency at Birth and atopic dermatitis (ad) is UNCERTAIN.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 1115), ('FULL_UNKNOWN', 1201)]	3	"[('UBERON_0000948', 'heart', 19, 'Cord'), ('UBERON_0001977', 'blood serum', 24, 'Serum'), ('CHEBI_27844', ""2',3'-cyclic AMP"", 30, '25-Hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('UBERON_0000104', 'life cycle', 120, 'Life'), ('UBERON_0000104', 'life cycle', 650, 'Life'), ('UBERON_0000948', 'heart', 710, 'Heart'), ('UBERON_0001977', 'blood serum', 1135, 'serum'), ('CHEBI_27300', 'vitamin D', 1141, 'vitamin D'), ('GO_0007567', 'parturition', 1165, 'birth')]"
S20-PMC4934634	PMC4934634	11/2015	S20-PMC4934634	['factors INFLUENCING Vitamin D status\nnumerous and diverse lifestyle choices, and environmental and Genetic FACTORS CAN alter Vitamin D status [6];figure 1.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 115)]	3	[('CHEBI_28384', 'vitamin K', 20, 'Vitamin D'), ('SO_0000704', 'gene', 99, 'genetic'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
S69-PMC4982007	PMC4982007	8/2016	S69-PMC4982007	['n \u2009=\u20095832: age 4\xa0years \u2003n \u2009=\u20095191; age 8\xa0years \u2003n \u2009=\u20097339; age 16\xa0yearsmaternal Gestational weight gain (kg)3 categories of weight gain1: less than recommended2: as recommended3: more than recommendedpre-Pregnancy weight (kg)school entry assessment score-4\xa0yearsiq- wechsler intelligence scale for children -iii-8\xa0yearsadequate final exam results-16\xa0yearschildren of women gained weight\u2009<\u2009expected-↓ school entry assessment score (-0.075 sd) and adequate final-exam results (or\u2009=\u20090.88); ↑weight gain - early and mid Pregnancy -↑school entry assessment score (0.072 and 0.077 sd)↑ weight gain in all three periods of Pregnancy-↑ iq at 8\xa0years (0.070 to 0.078 sd) and ↑pre-Pregnancy weight-↓ school entry assessment score (-0.004 sd/kg), iq (-0.004 sd) and the odds (or\u2009=\u20090.99) of achieving adequate final exam resultsconfounders adjusted for: the child’s sex, current age, ma; me, parity, pre-Pregnancy bmi, smoking and mode of Delivery16 medium\nbmi body mass index, qs quality score, rb risk of bias, ga Gestational age, ma maternal age, bwt Birthweight, ses socio-economic status, me maternal education, pe paternal education, miq maternal intelligence, he home environment, ms maternal smoking, bf breast-feeding, dm maternal diabetes, pih Pregnancy induced hypertension\n\ncaption (table-wrap): table 3\n\nsummary of the studies examining ASSOCIATIONS of maternal Vitamin D status with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb20gale c; 2008 \u2003n \u2009=\u2009178\u2003age 9\xa0years\u2003uk\u2003prospective longitudinalserum Vitamin D concentrations assessed at 28-42 weeks Gestation21.2\xa0% had <27.5\xa0nmol/l28.3\xa0% had 27.5-50\xa0nmol/lwechsler abbreviated scale of intelligencefull-scale, verbal or performance iqno association between Vitamin D concentrations and offspring iq (full-scale, verbal or performance)confounders adjusted for: unadjusted16 medium21whitehouse ajo; 2012\u2003age 5\xa0years ( n \u2009=\u2009534)\u2003age 10\xa0years ( n \u2009=\u2009474)\u2003australia\u2003prospective longitudinalserum Vitamin D concentrations assessed at 18\xa0weeks Gestation25.2\xa0% mothers had insufficiency (≤46\xa0nmol/l)(lowest quartile)peabody picture vocabulary test Receptive Languagechildren of mothers with Vitamin D insufficiency (lowest quartile (≤46\xa0nmol/l) were at INCREASED RISK (or\u2009=\u20091.97) of Language impairment compared to children of mothers without insufficiency (highest quartile (≥72\xa0nmol/l; or\u2009=\u20091.00)confounders adjusted for: ma, ms, parity, family income, season of maternal Blood sampling13 medium22morales\xa0e; 2012 \u2003n \u2009=\u20091820\u2003age 11-23 months\u2003spain\u2003prospective population based\u2003cohort studyplasma Vitamin D concentrations assessed during 12-23 weeks Gestation19.5\xa0% mothers had deficiency (<20\xa0ng/ml)31.5\xa0% had insufficiency (20-30\xa0ng/ml)bayley scales of infant development (mental (mdi) and psychomotor (pdi) developmental score)a positive linear ASSOCIATION between Vitamin D concentrations and mdi and pdiper 10\xa0ng/ml increase in Vitamin D concentrations mdi and pdi score increased by β\u2009=\u20090.79 and β\u2009=\u20090.88 points respectivelycompared to infants of deficient mothers, infants of mothers with normal level scored higher mdi (β\u2009=\u20092.60) and pdi (β\u2009=\u20092.32) points respectivelyconfounders adjusted for: the child’s sex, bwt, area of study, maternal country of origin, ma, parity, Pre-Pregnancy bmi, ses, me, ms, Alcohol and season15 medium\nqs quality score, rb risk of bias, ma maternal age, bwt Birthweight, me Maternal education, ms maternal smoking, bmi body mass index, ses socio-economic status\n\ncaption (table-wrap): table 4\n\nsummary of the studies examining ASSOCIATIONS of maternal Folate status with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb23wu btf; 2012 \u2003n \u2009=\u2009154\u2003age 18 months\u2003canada\u2003prospectiveplasma Folate and thcy concentrations assessed at 16 and 36\xa0weeks Gestationno Folate deficiency (plasma Folate <6.8\xa0nmol/l)high thcy not reportedbayley scales of infant developmentreceptive language, expressive language, Cognitive skills, fine motor and gross motorno ASSOCIATION of Folate and thcy with Cognitive functionconfounders adjusted for: the child’s sex, bf, ethnicity, ma, miq, maternal Fatty Acid level13 medium24tamura t; 2005 \u2003n \u2009=\u2009355\u2003age 5\xa0years\u2003usa\u2003prospective\u2003mothers participated in zinc supplementation trial during Pregnancyred cell and Plasma Folate concentrations – 19, 26 and 37\xa0weeks Gestation and thcy concentrations-26 and 37\xa0weekslow Folate-(Plasma Folate <11\xa0nmol/l)19\xa0weeks- 7.4\xa0%; 26\xa0weeks- 8.2\xa0%; 37\xa0weeks- 14.0\xa0%Red Cell Folate <430\xa0nmol/l)19\xa0weeks- 7.2\xa0%; 26\xa0weeks- 3.8\xa0%; 37\xa0weeks- 3.3\xa0%high thcy (thcy\u2009>\u20097\xa0μmol/l)26\xa0weeks- 8.4\xa0%; 37\xa0weeks- 22.1\xa0%differential ability scale (verbal, nonverbal and general iq), Visual and Auditory sequential Memory (Visual and Auditory Memory span)knox cube (attention span and Short-Term Memory)gross motor scale (gross Motor Development and grooved pegboard (manipulative dexterity)no difference in the mental and psychomotor developmental scores between children of mothers with normal and deficient Folate and thcy groups.']	[('SUPERFICIAL_RELATIONSHIP', 1338), ('IMPORTANT_CONSIDERATION', 2306), ('SUPERFICIAL_RELATIONSHIP', 2901), ('SUPERFICIAL_RELATIONSHIP', 3617), ('SUPERFICIAL_RELATIONSHIP', 4142)]	5	[('GO_0007565', 'female pregnancy', 80, 'gestational'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('GO_0007565', 'female pregnancy', 516, 'pregnancy'), ('GO_0007565', 'female pregnancy', 616, 'pregnancy'), ('GO_0007565', 'female pregnancy', 671, 'pregnancy'), ('GO_0007565', 'female pregnancy', 892, 'pregnancy'), ('GO_0007567', 'parturition', 927, 'delivery16'), ('GO_0007565', 'female pregnancy', 1004, 'gestational'), ('GO_0007596', 'blood coagulation', 1042, 'birthweight'), ('GO_0007565', 'female pregnancy', 1242, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1363, 'vitamin D'), ('GO_0050890', 'cognition', 1395, 'cognitive'), ('CHEBI_27300', 'vitamin D', 1611, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1660, 'gestation21'), ('CHEBI_27300', 'vitamin D', 1818, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2052, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2098, 'gestation25'), ('GO_0000724', 'double-strand break repair via homologous recombination', 2201, 'Receptive languageChildren'), ('CHEBI_27300', 'vitamin D', 2244, 'vitamin D'), ('GO_0006266', 'DNA ligation', 2336, 'language'), ('UBERON_0000178', 'blood', 2527, 'blood'), ('CHEBI_27300', 'vitamin D', 2650, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2703, 'gestation19'), ('CHEBI_27300', 'vitamin D', 2921, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2986, 'vitamin D'), ('GO_0007568', 'aging', 3332, 'pre'), ('GO_0007565', 'female pregnancy', 3336, 'pregnancy'), ('CHEBI_30879', 'alcohol', 3364, 'alcohol'), ('GO_0007596', 'blood coagulation', 3448, 'birthweight'), ('GO_0007618', 'mating', 3464, 'maternal'), ('CHEBI_30863', '5-azaorotic acid', 3642, 'folate'), ('GO_0050890', 'cognition', 3671, 'cognitive'), ('CHEBI_30863', '5-azaorotic acid', 3881, 'folate'), ('GO_0007565', 'female pregnancy', 3940, 'gestationNo'), ('CHEBI_30863', '5-azaorotic acid', 3952, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 3978, 'folate'), ('GO_0050890', 'cognition', 4095, 'cognitive'), ('CHEBI_30863', '5-azaorotic acid', 4157, 'folate'), ('GO_0050890', 'cognition', 4178, 'cognitive'), ('CHEBI_35366', 'fatty acid', 4272, 'fatty acid'), ('GO_0007605', 'sensory perception of sound', 4410, 'pregnancyRed'), ('UBERON_0001969', 'blood plasma', 4432, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 4439, 'folate'), ('GO_0007565', 'female pregnancy', 4483, 'gestation'), ('CHEBI_30863', '5-azaorotic acid', 4536, 'folate'), ('UBERON_0001969', 'blood plasma', 4544, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 4551, 'folate'), ('CL_0000232', 'erythrocyte', 4619, 'Red cell'), ('CHEBI_30863', '5-azaorotic acid', 4628, 'folate'), ('GO_0007601', 'visual perception', 4819, 'Visual'), ('GO_0006754', 'ATP biosynthetic process', 4830, 'Auditory ...'), ('GO_0007613', 'memory', 4850, 'Memory'), ('GO_0007601', 'visual perception', 4858, 'visual'), ('GO_0007605', 'sensory perception of sound', 4869, 'auditory'), ('GO_0007613', 'memory', 4878, 'memory'), ('GO_0007608', 'sensory perception of smell', 4920, 'short-term memory'), ('GO_0009653', 'anatomical structure morphogenesis', 4963, 'motor development'), ('CHEBI_30863', '5-azaorotic acid', 5145, 'folate')]
S75-PMC4982007	PMC4982007	8/2016	S75-PMC4982007	['m; 2010 \u2003n \u2009=\u20099983 14\xa0years \u2003n \u2009=\u200910474 16\xa0years\u2003finland\u2003prospective Birth cohort studyhb concentrations at 3rd 7th and 9th Gestational monthsanaemiaschool performance14\xa0years- self report16\xa0years- school report↑maternal hb at 9\xa0months-↑ total school performance score (β\u2009=\u20090.03) and theory score at 14\xa0years and total score at 16\xa0years offspring of mothers with anaemia –low school scores (or\u2009=\u2009-0.05 at 14\xa0years and (or\u2009=\u2009-0.06) at 16\xa0yearsconfounders adjusted for: the child’s sex, bwt, Pregnancy wanted or not, me, social class, parity, marital status, ms, maternal mental health status18 low40davidson pw; 2008 \u2003n \u2009=\u2009229\u2003age 5, 9, 25and 30\xa0months\u2003republic of seychelles\u2003longitudinal cohort studyiron- total body stores at 14-24 weeks of Gestation assessed before the start of iron supplementationbayley scales of infant development: mental development index (mdi) and psychomotor development index (pdi) (9 and 30\xa0months)infant Cognition (fagan infantest-novelty preference) and Visual expectation paradigm –Visual recognition Memory (9 and 25\xa0months)a-not-b and delayed spatial alternation: inhibition, Working Memory, Planning and attention (25\xa0months)no association between maternal iron stores and Cognitive function at any age.confounders adjusted for: the child’s sex, bwt, ma, ses, he, miq and both parents living with the child (yes/no)19 low41lewis sj; 2013 \u2003n \u2009=\u2009~3,500\u2003age 8\xa0years\u2003uk\u2003population based prospective birth cohorthb concentrationsbefore 18\xa0weekshb <11.0\xa0g/dl -8\xa0%after 28\xa0weekshb <11.0\xa0g/dl -30\xa0%wechsler intelligence scale for children-iii- full- scale iqno ASSOCIATION between maternal hb and child’s iqconfounders adjusted for: ga, me, the child’s genotype, Iron supplementation, population stratification15 medium42tran td; 2013 \u2003n \u2009=\u2009378\u2003age 6\xa0months\u2003vietnam\u2003population based prospective cohort studyiron deficiency anaemia (hb <11.0\xa0g/dl and Serum ferritin <15\xa0ng/ml) during 12-28 weeks of Gestation-16\xa0%bayley scales of infant and toddler development-iii edition-Cognitive scoreinfants of anaemic mothers scored 11.6 points (0.77sd) lower in bsid Cognitive scores compared to infants of non-anaemic mothers.confounders adjusted for: parity, ma, me, wealth index, the child’s Birth and current weight, family support, bf.18 low43zhou sj; 2006 \u2003n \u2009=\u2009302\u2003age 4\xa0years; australia\u2003double blind randomized controlled trialiron Supplements (20\xa0mg/day) or placebo from 20\xa0weeks Gestation until deliverycompliance-86\xa0%stanford binet intelligence scale – iq (Verbal Reasoning, Visual Reasoning, Quantitative Reasoning and Short-Term Memory)no difference between the children of supplement group and placebo group in the mean score of composite iq or any subscales iq or in the proportion of children whose iq fell 1 or 2 sd below the mean.confounders adjusted for: sex, Birth order, Gestational age, ma, me, pe, he, bf20 low44li q; 2009 \u2003n \u2009=\u20091305\u2003age 3, 6 and 12\xa0months\u2003double blind cluster randomized controlled trial\u2003china3 intervention groups (all received Folic Acid)Folic Acid alone400\xa0μg ( n \u2009=\u2009471)-controliron 60\xa0mg\u2009+\u2009Folic Acid400\xa0μg ( n \u2009=\u2009438)multiple Micronutrients ((b Vitamins (1,2,3 6 and 12), Vitamin A, d, c, e and minerals (zinc, Iodine, copper, Selenium)\u2009+\u2009iron 30\xa0mg\u2009+\u2009400\xa0μg Folic Acid)) ( n \u2009=\u2009396)daily supplementation from enrolment until Delivery; inadequate information about compliancebayley scales of Infant Development :mental (md) and Psychomotor Development (pd)no significant difference in infants md and pd score at 3 and 6\xa0months and pd score at 12\xa0months between Supplement groupsmean md score among children of multiple Micronutrient group increased by 1 to 1.22 points COMPARED to children of Folic Acid alone, or Folic Acid\u2009+\u2009Iron group at 12\xa0monthsconfounders adjusted for: infants age, sex, Gestational age, apgar score, bwt, infant health, maternal age and bmi, parental education, occupation, ses, number of tablets consumed19 low\nqs quality score , rb risk of bias , hb haemoglobin , ga Gestational age , ma maternal age , bwt birthweight , ses socio-economic status , me maternal education , pe paternal education , miq maternal intelligence , he home environment , ms maternal smoking , bf breast-feeding , bmi body mass index\n\ncaption (table-wrap): table 7\n\nsummary of the studies examining ASSOCIATIONS of maternal Carbohydrate/protein with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb45alderman h; 2014 \u2003n \u2009=\u20096774\u2003age 16-22 years\u2003double blind cluster randomized controlled trial\u2003gambiacarbohydrate/protein supplementsintervention group:2 biscuits daily (1015\xa0kcal Carbohydrate and 22\xa0g protein) from 20\xa0weeks of Gestation to Deliverycontrol group: same Supplements for 20\xa0weeks during Postpartum but not during Pregnancyno information about complianceraven’s progressive matrices- nonverbal reasoning abilitythe mill hill vocabulary testthe backward and forward digit-span testschooling achievement (questionnaire)no difference in any of the Cognitive test scores or schooling achievement between children whose mothers received thesupplements during Pregnancy and children whose mothers received Supplements during Postpartum.confounders adjusted for: the child’s sex, age, ga, me, pe, maternal height, parity, season of Birth, language and village allocation19 low\nqs quality score, rb risk of bias, ga Gestational age, me Maternal education, pe paternal education\n\nmaternal anthropometry (table\xa02)\nall were observational studies and from developed countries [8–19].']	[('SUPERFICIAL_RELATIONSHIP', 1587), ('ANOMALY_CURIOUS_FINDING', 3631), ('SUPERFICIAL_RELATIONSHIP', 4262)]	3	[('GO_0007567', 'parturition', 69, 'Birth'), ('GO_0007565', 'female pregnancy', 124, 'gestational'), ('GO_0007565', 'female pregnancy', 490, 'pregnancy'), ('GO_0007565', 'female pregnancy', 742, 'gestation'), ('GO_0050890', 'cognition', 933, 'cognition'), ('GO_0007601', 'visual perception', 984, 'Visual'), ('GO_0007601', 'visual perception', 1013, 'visual ...'), ('GO_0007613', 'memory', 1032, 'memory'), ('GO_0007631', 'feeding behavior', 1109, 'working memory'), ('GO_0006260', 'DNA replication', 1125, 'planning'), ('GO_0050890', 'cognition', 1207, 'cognitive'), ('CHEBI_24870', 'ion', 1689, 'iron'), ('UBERON_0001977', 'blood serum', 1876, 'serum'), ('GO_0007565', 'female pregnancy', 1924, 'gestation'), ('GO_0050890', 'cognition', 1998, 'cognitive'), ('GO_0050890', 'cognition', 2082, 'cognitive'), ('GO_0007567', 'parturition', 2210, 'birth'), ('CHEBI_33341', 'titanium atom', 2355, 'supplements'), ('GO_0007565', 'female pregnancy', 2404, 'gestation'), ('GO_0016055', 'Wnt signaling pathway', 2483, 'verbal reasoning'), ('GO_0007602', 'phototransduction', 2501, 'visual reasoning'), ('GO_0031028', 'septation initiation signaling', 2519, 'quantitative reasoning'), ('GO_0007608', 'sensory perception of smell', 2546, 'short-term memory'), ('GO_0007567', 'parturition', 2794, 'birth'), ('GO_0007565', 'female pregnancy', 2807, 'gestational'), ('CHEBI_30751', 'formic acid', 2985, 'folic acid'), ('CHEBI_30751', 'formic acid', 2996, 'Folic acid'), ('CHEBI_52727', 'ethyl nile blue A', 3051, 'folic acid400'), ('CHEBI_33839', 'macromolecule', 3088, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 3107, 'vitamins'), ('CHEBI_27300', 'vitamin D', 3134, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 3173, 'iodine'), ('CHEBI_27568', 'selenium atom', 3189, 'selenium'), ('CHEBI_30751', 'formic acid', 3221, 'folic acid'), ('GO_0007567', 'parturition', 3288, 'delivery'), ('GO_0060119', 'inner ear receptor cell development', 3354, 'Infant Development'), ('GO_0035210', 'prepupal development', 3390, 'Psychomotor development'), ('CHEBI_16158', 'steroid sulfate', 3523, 'supplement'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 3581, 'micronutrient'), ('CHEBI_30751', 'formic acid', 3655, 'folic acid'), ('CHEBI_30751', 'formic acid', 3676, 'folic acid'), ('CHEBI_24870', 'ion', 3689, 'iron'), ('GO_0007565', 'female pregnancy', 3756, 'gestational'), ('GO_0007565', 'female pregnancy', 3955, 'gestational'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 4287, 'carbohydrate'), ('GO_0050890', 'cognition', 4323, 'cognitive'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 4649, 'carbohydrate'), ('GO_0007565', 'female pregnancy', 4697, 'gestation'), ('GO_0051607', 'defense response to virus', 4710, 'deliveryControl'), ('CHEBI_33341', 'titanium atom', 4738, 'supplements'), ('GO_0007565', 'female pregnancy', 4770, 'postpartum'), ('GO_0007605', 'sensory perception of sound', 4796, 'pregnancyNo'), ('GO_0050890', 'cognition', 5027, 'cognitive'), ('GO_0007565', 'female pregnancy', 5136, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 5182, 'supplements'), ('GO_0007565', 'female pregnancy', 5201, 'postpartum'), ('GO_0007567', 'parturition', 5307, 'birth'), ('GO_0007565', 'female pregnancy', 5390, 'gestational'), ('GO_0007618', 'mating', 5410, 'maternal')]
S260-PMC4992225	PMC4992225	8/2016	S260-PMC4992225	['it is also POSSIBLE that AS a result of vascular changes in Pregnancy the maternal Cerebral environment is more vulnerable to inflammation PERHAPS, EXPLAINING IN PART the LINK between Vitamin D and depression in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 25), ('INCOMPLETE_EVIDENCE', 139), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('UBERON_0001893', 'telencephalon', 83, 'cerebral'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 212, 'pregnancy')]
S10-PMC4998950	PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
S43-PMC4998950	PMC4998950	4/2016	S43-PMC4998950	['our finding of a stronger ASSOCIATION between maternal hypovitaminosis d and asd with intellectual disability than without intellectual disability is IN LINE WITH migrant STUDIES, DEMONSTRATING that offspring risk of severe forms of asd – BUT NOT asperger’s syndrome or asd without intellectual disability – is increased in migrant populations where Vitamin D deficiency is highly prevalent.3–6,8there is also MOUNTING EVIDENCE that environmental FACTORS are more RELEVANT (THAN Genetic factors) for the development of lower-functioning asd.2we, as well as others,6FURTHER OBSERVED heterogeneity in the ASSOCIATIONS between Vitamin D deficiency and asd between children with and without maternal migrant history.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('ANOMALY_CURIOUS_FINDING', 239), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 447), ('IMPORTANT_CONSIDERATION', 464), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 474), ('INCOMPLETE_EVIDENCE', 564), ('INCOMPLETE_EVIDENCE', 573), ('SUPERFICIAL_RELATIONSHIP', 603)]	13	[('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('SO_0000704', 'gene', 479, 'genetic'), ('CHEBI_27300', 'vitamin D', 624, 'vitamin D')]
S13-PMC5014971	PMC5014971	8/2016	S13-PMC5014971	['the geographic expansion of humanity, the modern environment, and medical CONCERNS over the sequela of extensive sun exposure (e.g., melanoma) have created conditions where for much of modern humanity Endogenous Vitamin D Production is LIKELY far below that of our ancestors.']	[('IMPORTANT_CONSIDERATION', 74), ('PROBABLE_UNDERSTANDING', 236)]	2	[('GO_0009790', 'embryo development', 201, 'endogenous'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 212, 'vitamin D production')]
S116-PMC5014971	PMC5014971	8/2016	S116-PMC5014971	['finally, the fact that Vitamin D levels in our ancient ancestors LIKELY exceeded the iom recommendations does NOT PROVE that those higher levels are conducive to better health and wellbeing in the modern environment.']	[('PROBABLE_UNDERSTANDING', 65), ('ANOMALY_CURIOUS_FINDING', 110), ('PROBABLE_UNDERSTANDING', 114)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
S4-PMC5028238	PMC5028238	10/2016	S4-PMC5028238	['we DESCRIBE the functional environment around Dhcr7, including Pharmacological Dhcr7 Inhibitors and Cholesterol and Vitamin D synthesis.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('PR_000006474', 'ATP-dependent RNA helicase A', 46, 'DHCR7'), ('CHEBI_52217', 'pharmaceutical', 63, 'pharmacological'), ('PR_000006474', 'ATP-dependent RNA helicase A', 79, 'DHCR7'), ('CHEBI_35222', 'inhibitor', 85, 'inhibitors'), ('CHEBI_16113', 'cholesterol', 100, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S0-PMC5042197	PMC5042197	9/2016	S0-PMC5042197	['prevalence and RISK FACTORS for low Vitamin D status among breastfeeding mother–infant dyads in an environment with abundant sunshine\n\nabstract\n\npurpose\nevaluation of Vitamin D (vd) status and RISK FACTORS for low vd among breastfeeding mother–infant dyads in a population at high RISK for vd deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 281)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
S0-PMC5062906	PMC5062906	10/2016	S0-PMC5062906	['maternal Vitamin D depletion alters Dna Methylation at Imprinted loci in multiple generations\n\nabstract\n\nbackground\nenvironmental perturbation of epigenetic mechanisms is LINKED to a GROWING NUMBER OF diseases.']	[('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 191)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 55, 'imprinted')]
S120-PMC5084016	PMC5084016	10/2016	S120-PMC5084016	['the Endogenous Synthesis Of Vitamin D requires exposure to ultraviolet radiation with a wavelength between 290 and 315 nm, and is INFLUENCED by several FACTORS, RELATED to both the Individual’s characteristics (such as sex and phenotype, weight), and environmental factors (the degree of physical activity, latitude, season, time of exposure to sunlight, pollution, use of sunscreens and supplements).']	[('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 161)]	3	[('GO_0009790', 'embryo development', 4, 'endogenous'), ('GO_0030474', 'spindle pole body duplication', 15, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 36, 'D'), ('NCBITaxon_1', 'root', 181, 'individual')]
S50-PMC5310660	PMC5310660	1/2017	S50-PMC5310660	['Genes ASSOCIATED with many Autoimmune diseases are enriched for Vitamin D receptor-Binding Sites [19-21], SUGGESTING that the combined EFFECT of Vitamin D deficiency, Genetic variation, and exposure to other environmental agents MAY concur in the pathogenesis.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 229)]	4	[('SO_0000704', 'gene', 0, 'Genes'), ('UBERON_0001442', 'skeleton of manus', 27, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('SO_0000409', 'binding_site', 83, 'binding sites'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('SO_0000704', 'gene', 167, 'genetic')]
S304-PMC5351212	PMC5351212	3/2017	S304-PMC5351212	['finally, GIVEN that mia and maternal Vitamin D deficiency are both risk-modifying factors for autism and GIVEN that the distinct OVERLAP in behavioral phenotypes produced in the Animal MODELS of these environmental RISK FACTORS, we ADDRESSED the issue of WHETHER mia induces Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 215), ('QUESTION_ANSWERED_BY_THIS_WORK', 232), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 178, 'animal'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
S93-PMC5405075	PMC5405075	4/2017	S93-PMC5405075	['a plethora of environmental and Genetic/epigenetic FACTORS CONTRIBUTE in a COMPLEX manner to a PARTLY understood pathogenesis, WHILE the shifted Vitamin D Metabolism during Pregnancy is also NOT FULLY ELUCIDATED.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 59), ('DIFFICULT_TASK', 75), ('INCOMPLETE_EVIDENCE', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 191)]	6	[('SO_0000704', 'gene', 32, 'genetic'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 145, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
S265-PMC5513133	PMC5513133	7/2017	S265-PMC5513133	['DESPITE the clear ASSOCIATION of Serum deficiency with pe, a better understanding of the variable IMPACT of supplementation IS NEEDED to identify POTENTIAL of Genetic and environmental INTERACTIONS, as well as pre-Conception data TO IDENTIFY the CRITICAL time window for therapeutic potential of Vitamin D, if any.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 230), ('IMPORTANT_CONSIDERATION', 246)]	8	[('UBERON_0001977', 'blood serum', 33, 'serum'), ('SO_0000704', 'gene', 159, 'genetic'), ('GO_0007620', 'copulation', 214, 'conception'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D')]
S44-PMC5640793	PMC5640793	9/2017	S44-PMC5640793	"[""the lancet 's 2013 maternal and child nutrition series RECOMMENDS ten nutrition-specific INTERVENTIONS, including sufficient and diverse Foods for adolescent girls and women; iron, Folic Acid, and Calcium supplementation in Pregnancy; good infant and young child Feeding practices; Vitamin A, iron, and preventive zinc supplementation for children; and treatment for moderate and severe acute malnutrition.5strikingly HOWEVER, expanding the coverage of these nutrition-specific INTERVENTIONS to 90% of mothers and children would only reduce stunting by an ESTIMATED 20%.5larger reductions than these REQUIRE increasing access to family Planning, health services for Pregnant women and children, investments in Water and sanitation, social safety nets, girls' education, and women's empowerment.6a pragmatic approach to design community STRATEGIES for stunting reduction MIGHT THEREFORE be to prioritise action on immediate determinants (infection control, nutrition, and care in the first 1000 days) while providing an enabling social environment for changes in more distal determinants, for example by sharing information about health, nutrition, and sanitation entitlements, and bolstering women's agency.""]"	[('FUTURE_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('ANOMALY_CURIOUS_FINDING', 418), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 556), ('FUTURE_WORK', 600), ('IMPORTANT_CONSIDERATION', 600), ('FUTURE_WORK', 836), ('INCOMPLETE_EVIDENCE', 870), ('PROBABLE_UNDERSTANDING', 876)]	11	[('CHEBI_33290', 'food', 137, 'foods'), ('CHEBI_30751', 'formic acid', 181, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 197, 'calcium'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007631', 'feeding behavior', 263, 'feeding'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin A'), ('GO_0006260', 'DNA replication', 636, 'planning'), ('GO_0007565', 'female pregnancy', 666, 'pregnant'), ('CHEBI_15377', 'water', 710, 'water')]
S48-PMC5685050	PMC5685050	10/2014	S48-PMC5685050	['in summary, DESPITE a location near the equator where sunlight is available year round, thai People are at risk for Vitamin D insufficiency DUE TO environmental, cultural, lifestyle and dietary factors.']	[('ANOMALY_CURIOUS_FINDING', 12), ('PROBLEM_COMPLICATION', 140)]	2	[('NCBITaxon_10088', 'Mus <genus>', 93, 'people'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S10-PMC5716389	PMC5716389	9/2017	S10-PMC5716389	['maternal nutritional status, and exposure during fetal Life to an inadequately nurturing environment, COULD THUS IMPACT fetal Immune Development [3,4], in particular, Micronutrients including zinc, iron, Vitamin A and protein energy malnutrition (pem).']	[('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('UBERON_0000104', 'life cycle', 55, 'life'), ('GO_0001822', 'kidney development', 126, 'immune development'), ('UBERON_0002405', 'immune system', 126, 'immune'), ('CHEBI_33839', 'macromolecule', 167, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A')]
S14-PMC5952272	PMC5952272	5/2018	S14-PMC5952272	['approximately 1 in 68 children aged 8\u2009years living in sites participating in the addm network surveillance areas (usa) met the asd case criteria for the 2012 surveillance year.1some HYPOTHESES were SUGGESTED to explain this increase, such as an increased awareness, improved detection, expanding definition, or an actual increase in incidence or a combination of these FACTORS.2ALTHOUGH both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function–RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.3SEVERAL RECENT STUDIES have put FORWARD hypotheses to explain the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 369), ('ANOMALY_CURIOUS_FINDING', 377), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 440), ('INCOMPLETE_EVIDENCE', 476), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 554), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 634), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 668), ('INCOMPLETE_EVIDENCE', 677), ('FUTURE_WORK', 701), ('SUPERFICIAL_RELATIONSHIP', 748)]	15	[('SO_0000704', 'gene', 392, 'genetic'), ('UBERON_0002405', 'immune system', 538, 'immune'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D'), ('CHEBI_30751', 'formic acid', 594, 'folic acid'), ('GO_0008152', 'metabolic process', 610, 'metabolic'), ('CHEBI_30751', 'formic acid', 773, 'folic acid'), ('CHEBI_27300', 'vitamin D', 788, 'vitamin D')]
S14-PMC5956785	PMC5956785	5/2018	S14-PMC5956785	['Vitamin D status is POTENTIALLY GOVERNED by these same FACTORS; Vitamin D receptor genotype, ethnically RELATED skin tone and clothing, environmental variations in exposure to ultraviolet b radiation RELATING to the latitude of residence and season, and Vitamin D nutritional intake are FACTORS that Modulate Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 200), ('SUPERFICIAL_RELATIONSHIP', 287)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0065007', 'biological regulation', 300, 'modulate'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D')]
S211-PMC5956785	PMC5956785	5/2018	S211-PMC5956785	['by exploring the factors that INFLUENCE Vitamin D status (genetics, environment, and nutrition), we will be BETTER able to discern an ASSOCIATION between Vitamin D and jia.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
S257-PMC5956785	PMC5956785	5/2018	S257-PMC5956785	['INVESTIGATING Genetic, nutritional and environmental factors that INFLUENCE Vitamin D in jia COULD HELP inform ways in which Vitamin D status INFLUENCES the occurrence and activity of jia.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 93), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
S283-PMC5956785	PMC5956785	5/2018	S283-PMC5956785	['INVESTIGATING the Genetic and environmental ROLE that Vitamin D plays in the PREVENTION and Control of jia in the same children will HELP to tease out the multifaceted ROLE played by Vitamin D in this disease.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 77), ('FUTURE_WORK', 133), ('SUPERFICIAL_RELATIONSHIP', 168)]	5	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0065007', 'biological regulation', 92, 'control'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
S23-PMC6039335	PMC6039335	7/2018	S23-PMC6039335	['factors AFFECTING imf deposition can be sub-categorized into Genetic (breed and sex differences, heritability), management (weaning age, castration, slaughter weight and age, and environment), and nutritional factors (Fat Metabolism, Fat Digestion and absorption, Glucose/Starch availability, roughage vs concentrate ratio, dietary energy and protein levels, Vitamins A, d, and c levels, fetal and neonatal nutritional programming, and stage-specific Feeding systems).']	[('SUPERFICIAL_RELATIONSHIP', 8)]	1	[('SO_0000704', 'gene', 61, 'genetic'), ('GO_0006631', 'fatty acid metabolic process', 218, 'fat metabolism'), ('GO_0009566', 'fertilization', 234, 'fat digestion'), ('CHEBI_17234', 'glucose', 264, 'glucose'), ('CHEBI_28017', 'starch', 272, 'starch'), ('CHEBI_27300', 'vitamin D', 359, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 368, 'A'), ('GO_0007631', 'feeding behavior', 451, 'feeding')]
